Id,Name,Type,VectorableProperty
2,HOMAIR,Phenotype,HOMAIR
19,HDL,Phenotype,HDL
22,Homair Adj Bmi,Phenotype,Homair Adj Bmi
29,Fasting Blood Glucose,Phenotype,Fasting Blood Glucose
59,T2D,Phenotype,T2D
65,Insulin Fold Change Adj Bmi,Phenotype,Insulin Fold Change Adj Bmi
68,BMI,Phenotype,BMI
72,LDL,Phenotype,LDL
77,Fasting Blood Insulin,Phenotype,Fasting Blood Insulin
200,Schizophrenia,Phenotype,Schizophrenia
671,T2D 2024,Phenotype,T2D 2024
950,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi,Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi
1164,Handedness,Phenotype,Handedness
1239,T1D,Phenotype,T1D
1479,Insulin Sensitivity Index Adj Bmi,Phenotype,Insulin Sensitivity Index Adj Bmi
1603,vatAsatRatio,Phenotype,vatAsatRatio
1680,HbA1c,Phenotype,HbA1c
1682,FastingInsulin,Phenotype,FastingInsulin
1709,Coronary Artery Disease,Phenotype,Coronary Artery Disease
2193,Abdominal Subcutaneous Adipose Tissue Adj Bmi,Phenotype,Abdominal Subcutaneous Adipose Tissue Adj Bmi
2326,Waist-Hip Ratio Adj Bmi,Phenotype,Waist-Hip Ratio Adj Bmi
2327,VATadjBMI,Phenotype,VATadjBMI
2331,Proinsulin,Phenotype,Proinsulin
2332,SHBG_LpA,Phenotype,SHBG_LpA
2333,Beta_Cell_2,Phenotype,Beta_Cell_2
2334,Obesity,Phenotype,Obesity
2335,Lipodystrophy_1,Phenotype,Lipodystrophy_1
2336,Bilirubin,Phenotype,Bilirubin
2337,Liver_Lipid,Phenotype,Liver_Lipid
2338,Lipodystrophy_2,Phenotype,Lipodystrophy_2
2339,Hyper_Insulin,Phenotype,Hyper_Insulin
2340,ALP_Neg,Phenotype,ALP_Neg
2341,Total Cholesterol,Phenotype,Total Cholesterol
2342,Beta_Cell_1,Phenotype,Beta_Cell_1
3682,Type 2 Diabetes Mellitus,Phenotype,Type 2 Diabetes Mellitus
5360,Fasting Glucose Magic,Phenotype,Fasting Glucose Magic
5851,Hba1C Magic,Phenotype,Hba1C Magic
6291,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat),Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat)
11986,Fasting Insulin Magic,Phenotype,Fasting Insulin Magic
12537,Hba1C Hm3,Phenotype,Hba1C Hm3
12788,Type 1 Diabetes Mellitus,Phenotype,Type 1 Diabetes Mellitus
16061,Urate Levels,Phenotype,Urate Levels
16063,Triglyceride To Hdl Cholesterol Ratio,Phenotype,Triglyceride To Hdl Cholesterol Ratio
16065,Sex Hormone-Binding Globulin Levels Adjusted For Bmi,Phenotype,Sex Hormone-Binding Globulin Levels Adjusted For Bmi
16067,Height,Phenotype,Height
16069,Total Esterified Cholesterol Levels,Phenotype,Total Esterified Cholesterol Levels
16073,Testasv_38 (Ruminococcus) Abundance,Phenotype,Testasv_38 (Ruminococcus) Abundance
16075,Subclinical Hypothyroidism In Pregnancy,Phenotype,Subclinical Hypothyroidism In Pregnancy
16077,Electrocardiogram Morphology (Amplitude At Temporal Datapoints),Phenotype,Electrocardiogram Morphology (Amplitude At Temporal Datapoints)
16080,Non-Hdl Cholesterol Levels,Phenotype,Non-Hdl Cholesterol Levels
16083,Atrial Fibrillation,Phenotype,Atrial Fibrillation
16086,Low Density Lipoprotein Cholesterol Levels,Phenotype,Low Density Lipoprotein Cholesterol Levels
16088,Phospholipid Levels In Medium Vldl,Phenotype,Phospholipid Levels In Medium Vldl
16091,Phospholipids To Total Lipids Ratio In Very Large Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Very Large Hdl
16093,Breast Cancer,Phenotype,Breast Cancer
16095,Coenzyme Q10 Levels,Phenotype,Coenzyme Q10 Levels
16097,Anxiety Severity X Playing Computer Games Interaction,Phenotype,Anxiety Severity X Playing Computer Games Interaction
16099,Hematocrit,Phenotype,Hematocrit
16103,Systolic Blood Pressure,Phenotype,Systolic Blood Pressure
16105,Sarcalumenin Levels,Phenotype,Sarcalumenin Levels
16108,Appendicular Lean Mass,Phenotype,Appendicular Lean Mass
16112,Memory Decline In Impaired Cognition X Sex Interaction,Phenotype,Memory Decline In Impaired Cognition X Sex Interaction
16114,Bone Mineral Density Mean,Phenotype,Bone Mineral Density Mean
16116,F-Acquired Taste Liking (Derived Food-Liking Factor),Phenotype,F-Acquired Taste Liking (Derived Food-Liking Factor)
16118,Glycine Levels,Phenotype,Glycine Levels
16121,Medication Use (Thyroid Preparations),Phenotype,Medication Use (Thyroid Preparations)
16123,Waist-To-Hip Ratio Adjusted For Bmi,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi
16125,Amyotrophic Lateral Sclerosis (Sporadic),Phenotype,Amyotrophic Lateral Sclerosis (Sporadic)
16127,"Facial Morphology (Factor 2, Vertical Position Of Orbits Relative To Midface)",Phenotype,"Facial Morphology (Factor 2, Vertical Position Of Orbits Relative To Midface)"
16129,Smoking Initiation,Phenotype,Smoking Initiation
16134,Brainstem Volume,Phenotype,Brainstem Volume
16136,Peptidyl-Glycine Alpha-Amidating Monooxygenase Levels (Pam.5620.13.3),Phenotype,Peptidyl-Glycine Alpha-Amidating Monooxygenase Levels (Pam.5620.13.3)
16138,Wg Lh Intensity-Contrast Rostralmiddlefrontal,Phenotype,Wg Lh Intensity-Contrast Rostralmiddlefrontal
16140,Kifbp/Lyn Protein Level Ratio,Phenotype,Kifbp/Lyn Protein Level Ratio
16142,Concentration Of Small Vldl Particles,Phenotype,Concentration Of Small Vldl Particles
16144,Total Phf-Tau (Snp X Snp Interaction),Phenotype,Total Phf-Tau (Snp X Snp Interaction)
16146,Hypertension (Confirmatory Factor Analysis Factor 12),Phenotype,Hypertension (Confirmatory Factor Analysis Factor 12)
16149,Blood Protein Levels,Phenotype,Blood Protein Levels
16151,Migraine Or Glucose Levels,Phenotype,Migraine Or Glucose Levels
16153,Protein Levels In Obesity,Phenotype,Protein Levels In Obesity
16156,Mean Arterial Pressure,Phenotype,Mean Arterial Pressure
16158,Pancreatic Triacylglycerol Lipase Levels,Phenotype,Pancreatic Triacylglycerol Lipase Levels
16160,Peak Height Velocity,Phenotype,Peak Height Velocity
16162,Ascending Aorta Distensibility,Phenotype,Ascending Aorta Distensibility
16165,Liver Enzyme Levels (Alkaline Phosphatase),Phenotype,Liver Enzyme Levels (Alkaline Phosphatase)
16167,Highest Math Class Taken (Mtag),Phenotype,Highest Math Class Taken (Mtag)
16169,Otu99_108 (Cytophagales) Prevalence,Phenotype,Otu99_108 (Cytophagales) Prevalence
16171,Mean Corpuscular Volume,Phenotype,Mean Corpuscular Volume
16175,Educational Attainment,Phenotype,Educational Attainment
16179,Hemoglobin Levels,Phenotype,Hemoglobin Levels
16181,Apolipoprotein B Levels,Phenotype,Apolipoprotein B Levels
16183,Total Lipid Levels In Ldl,Phenotype,Total Lipid Levels In Ldl
16186,Cerebrospinal Fluid Biomarker Levels,Phenotype,Cerebrospinal Fluid Biomarker Levels
16190,Platelet Count,Phenotype,Platelet Count
16192,Lymphocyte Percentage Of White Cells,Phenotype,Lymphocyte Percentage Of White Cells
16194,Triglyceride Levels,Phenotype,Triglyceride Levels
16196,Core Binding Factor Acute Myeloid Leukemia,Phenotype,Core Binding Factor Acute Myeloid Leukemia
16198,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl
16201,Red Cell Distribution Width,Phenotype,Red Cell Distribution Width
16203,Phospholipid Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipid Levels In Chylomicrons And Extremely Large Vldl
16205,Breast Cancer And/Or Colorectal Cancer,Phenotype,Breast Cancer And/Or Colorectal Cancer
16207,Medication Use (Drugs Used In Diabetes),Phenotype,Medication Use (Drugs Used In Diabetes)
16210,Red Blood Cell Count,Phenotype,Red Blood Cell Count
16212,Ulcerative Colitis,Phenotype,Ulcerative Colitis
16214,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy),Phenotype,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy)
16216,Estimated Glomerular Filtration Rate (Cystatin C),Phenotype,Estimated Glomerular Filtration Rate (Cystatin C)
16219,Estimated Glomerular Filtration Rate After 1 Year In Renal Transplantation (Donor Effect),Phenotype,Estimated Glomerular Filtration Rate After 1 Year In Renal Transplantation (Donor Effect)
16221,Mean Platelet Volume,Phenotype,Mean Platelet Volume
16225,Trail Levels,Phenotype,Trail Levels
16227,Cholesterol To Total Lipids Ratio In Medium Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Medium Vldl
16230,Vertical Cup-Disc Ratio,Phenotype,Vertical Cup-Disc Ratio
16234,Body Mass Index (Mtag),Phenotype,Body Mass Index (Mtag)
16238,"Anorexia Nervosa, Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Bipolar Disorder, Major Depression, Obsessive-Compulsive Disorder, Schizophrenia, Or Tourette Syndrome (Pleiotropy)",Phenotype,"Anorexia Nervosa, Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Bipolar Disorder, Major Depression, Obsessive-Compulsive Disorder, Schizophrenia, Or Tourette Syndrome (Pleiotropy)"
16240,Lung Adenocarcinoma,Phenotype,Lung Adenocarcinoma
16243,Pulse Pressure,Phenotype,Pulse Pressure
16245,Adult Body Size,Phenotype,Adult Body Size
16247,Small Cell Lung Carcinoma,Phenotype,Small Cell Lung Carcinoma
16249,Migraine Without Aura,Phenotype,Migraine Without Aura
16252,Protein S100-A4 Levels (S100A4.14116.129.3),Phenotype,Protein S100-A4 Levels (S100A4.14116.129.3)
16255,Triglycerides,Phenotype,Triglycerides
16258,Waist-To-Hip Ratio Adjusted For Body Mass Index,Phenotype,Waist-To-Hip Ratio Adjusted For Body Mass Index
16260,Wg Rh Intensity-Contrast Rostralanteriorcingulate,Phenotype,Wg Rh Intensity-Contrast Rostralanteriorcingulate
16262,Basal Cell Carcinoma,Phenotype,Basal Cell Carcinoma
16264,Protein Quantitative Trait Loci (Liver),Phenotype,Protein Quantitative Trait Loci (Liver)
16266,Cerebellin-4 Levels,Phenotype,Cerebellin-4 Levels
16268,Low Tan Response,Phenotype,Low Tan Response
16270,Fat-Free Mass,Phenotype,Fat-Free Mass
16275,Myocardial Infarction,Phenotype,Myocardial Infarction
16277,High Density Lipoprotein Cholesterol Levels,Phenotype,High Density Lipoprotein Cholesterol Levels
16279,Folate Pathway Vitamin Levels,Phenotype,Folate Pathway Vitamin Levels
16281,Inflammatory Bowel Disease,Phenotype,Inflammatory Bowel Disease
16284,Cholesteryl Esters To Total Lipids Ratio In Idl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Idl
16287,Age At First Sexual Intercourse,Phenotype,Age At First Sexual Intercourse
16290,Cholesteryl Ester Levels In Very Large Hdl,Phenotype,Cholesteryl Ester Levels In Very Large Hdl
16293,Melanoma,Phenotype,Melanoma
16295,Diastolic Blood Pressure (Mtag),Phenotype,Diastolic Blood Pressure (Mtag)
16297,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test)
16299,Multiple Sclerosis,Phenotype,Multiple Sclerosis
16303,Dementia With Lewy Bodies In Apoe E4- Carriers,Phenotype,Dementia With Lewy Bodies In Apoe E4- Carriers
16305,Cigarette Consumption X Hours Spent Using Computers Interaction,Phenotype,Cigarette Consumption X Hours Spent Using Computers Interaction
16307,Calcium Levels,Phenotype,Calcium Levels
16309,Body Fat Percentage,Phenotype,Body Fat Percentage
16311,Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ Levels
16313,Triglyceride Levels In Ldl,Phenotype,Triglyceride Levels In Ldl
16315,Psp94 Plasma Levels,Phenotype,Psp94 Plasma Levels
16317,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis)
16319,Primary Biliary Cholangitis,Phenotype,Primary Biliary Cholangitis
16321,Waist Circumference Adjusted For Body Mass Index,Phenotype,Waist Circumference Adjusted For Body Mass Index
16323,Central Nucleus Volume,Phenotype,Central Nucleus Volume
16325,Dab2/Tbl1X Protein Level Ratio,Phenotype,Dab2/Tbl1X Protein Level Ratio
16328,Severe Covid-19 Infection,Phenotype,Severe Covid-19 Infection
16333,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid)
16335,Ccl5/Ccn2 Protein Level Ratio,Phenotype,Ccl5/Ccn2 Protein Level Ratio
16337,Coronary Artery Disease (Mtag),Phenotype,Coronary Artery Disease (Mtag)
16339,Phospholipids To Total Lipids Ratio In Medium Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Medium Hdl
16343,Vertex-Wise Cortical Thickness,Phenotype,Vertex-Wise Cortical Thickness
16346,Platelet Count During  First Trimester Of Pregnancy,Phenotype,Platelet Count During  First Trimester Of Pregnancy
16348,Hexanoylcarnitine Levels,Phenotype,Hexanoylcarnitine Levels
16350,Complement Factor H Levels,Phenotype,Complement Factor H Levels
16352,Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+Nh4]1+ Levels
16356,Hdl Cholesterol,Phenotype,Hdl Cholesterol
16358,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test)
16360,Insomnia,Phenotype,Insomnia
16363,Short Sleep Duration (<5 Hours),Phenotype,Short Sleep Duration (<5 Hours)
16366,Thyroid Stimulating Hormone Levels,Phenotype,Thyroid Stimulating Hormone Levels
16368,Serum Metabolite Levels,Phenotype,Serum Metabolite Levels
16370,Gamma Glutamyl Transferase Levels,Phenotype,Gamma Glutamyl Transferase Levels
16372,Lung Cancer (Snp X Snp Interaction),Phenotype,Lung Cancer (Snp X Snp Interaction)
16374,Heel Bone Mineral Density,Phenotype,Heel Bone Mineral Density
16377,Nickel Levels,Phenotype,Nickel Levels
16379,Predicted Visceral Adipose Tissue,Phenotype,Predicted Visceral Adipose Tissue
16382,Phospholipids To Total Lipids Ratio In Small Ldl,Phenotype,Phospholipids To Total Lipids Ratio In Small Ldl
16384,Triacylglycerol(52:4)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(52:4)_[M+Nh4]1+ Levels
16388,Sulfatase-Modifying Factor 2 Levels,Phenotype,Sulfatase-Modifying Factor 2 Levels
16391,Phosphatidylglycerol (36:2) Levels,Phenotype,Phosphatidylglycerol (36:2) Levels
16393,Alcohol Dehydrogenase [Nadp(+)] Levels,Phenotype,Alcohol Dehydrogenase [Nadp(+)] Levels
16395,Ascending Aorta Diameter,Phenotype,Ascending Aorta Diameter
16397,High Light Scatter Reticulocyte Percentage Of Red Cells,Phenotype,High Light Scatter Reticulocyte Percentage Of Red Cells
16399,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels,Phenotype,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels
16401,Obesity-Related Traits,Phenotype,Obesity-Related Traits
16403,Cortical Surface Area (Mostest),Phenotype,Cortical Surface Area (Mostest)
16405,Diastolic Blood Pressure,Phenotype,Diastolic Blood Pressure
16407,Hip Circumference Adjusted For Bmi,Phenotype,Hip Circumference Adjusted For Bmi
16409,C-Reactive Protein,Phenotype,C-Reactive Protein
16411,Neutrophil Count,Phenotype,Neutrophil Count
16413,Ldl Cholesterol,Phenotype,Ldl Cholesterol
16415,Post Bronchodilator Fev1/Fvc Ratio,Phenotype,Post Bronchodilator Fev1/Fvc Ratio
16417,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+Nh4]1+ Levels
16419,Phosphatidylethanolamine_38:4_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine_38:4_[M-H]1- Levels
16421,Free Cholesterol Levels In Very Large Vldl,Phenotype,Free Cholesterol Levels In Very Large Vldl
16423,Lysophosphatidylcholine(20:4)_[M+H]1+ Levels,Phenotype,Lysophosphatidylcholine(20:4)_[M+H]1+ Levels
16425,Cholesterol_[M+H-H2O]1+ Levels,Phenotype,Cholesterol_[M+H-H2O]1+ Levels
16427,Age At Menopause,Phenotype,Age At Menopause
16430,Spatial Qrs-T Angle,Phenotype,Spatial Qrs-T Angle
16432,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435),Phenotype,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435)
16434,Keratoconus,Phenotype,Keratoconus
16437,Serum Levels Of Protein Cd244,Phenotype,Serum Levels Of Protein Cd244
16440,Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ Levels
16442,Non-Del(5Q) Myelodysplastic Syndromes,Phenotype,Non-Del(5Q) Myelodysplastic Syndromes
16444,White Blood Cell Count,Phenotype,White Blood Cell Count
16446,Total Cholesterol Levels,Phenotype,Total Cholesterol Levels
16448,Body Mass Index In Physically Active Individuals,Phenotype,Body Mass Index In Physically Active Individuals
16450,Triglycerides In Medium Hdl (Ukb Data Field 23571),Phenotype,Triglycerides In Medium Hdl (Ukb Data Field 23571)
16454,Light Vs. Dark Hair Color,Phenotype,Light Vs. Dark Hair Color
16456,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
16459,Schizophrenia (Mtag),Phenotype,Schizophrenia (Mtag)
16463,A Body Shape Index,Phenotype,A Body Shape Index
16465,Phosphatidylethanolamine (16:0_18:2) Levels,Phenotype,Phosphatidylethanolamine (16:0_18:2) Levels
16468,Triacylglycerol_56:7_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol_56:7_[M+Nh4]1+ Levels
16470,Asthma,Phenotype,Asthma
16472,Thromboembolic Events In Sickle Cell Disease,Phenotype,Thromboembolic Events In Sickle Cell Disease
16474,Serum Urate Levels,Phenotype,Serum Urate Levels
16476,Idp Dmri Probtrackx Od Slf R,Phenotype,Idp Dmri Probtrackx Od Slf R
16478,Interleukin-1 Alpha Levels,Phenotype,Interleukin-1 Alpha Levels
16480,Corneal Resistance Factor,Phenotype,Corneal Resistance Factor
16482,Cholesterol Levels In Small Ldl,Phenotype,Cholesterol Levels In Small Ldl
16484,Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ Levels
16487,Idp T1 First Left Pallidum Volume,Phenotype,Idp T1 First Left Pallidum Volume
16489,Fasting Glucose,Phenotype,Fasting Glucose
16491,Crohn'S Disease,Phenotype,Crohn'S Disease
16493,Metabolic Syndrome,Phenotype,Metabolic Syndrome
16495,Neutral And Basic Amino Acid Transport Protein Rbat Levels,Phenotype,Neutral And Basic Amino Acid Transport Protein Rbat Levels
16498,Loneliness,Phenotype,Loneliness
16502,Urate Levels In Overweight Individuals,Phenotype,Urate Levels In Overweight Individuals
16506,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+Nh4]1+ Levels
16508,Subcortical Volume (Mostest),Phenotype,Subcortical Volume (Mostest)
16510,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test)
16512,Hdl Cholesterol Levels In Current Drinkers,Phenotype,Hdl Cholesterol Levels In Current Drinkers
16514,Epididymal-Specific Lipocalin-8 Levels,Phenotype,Epididymal-Specific Lipocalin-8 Levels
16517,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
16519,Cholesterol Esters In Very Large Hdl,Phenotype,Cholesterol Esters In Very Large Hdl
16521,Neuroticism General Factor,Phenotype,Neuroticism General Factor
16523,Eosinophil Counts,Phenotype,Eosinophil Counts
16525,Multi-Trait Sum Score,Phenotype,Multi-Trait Sum Score
16527,Nonsyndromic Cleft Palate,Phenotype,Nonsyndromic Cleft Palate
16530,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
16533,Type 1 Diabetes,Phenotype,Type 1 Diabetes
16535,Eotaxin Level In Chronic Kidney Disease With Hypertension And No Diabetes (5301_7),Phenotype,Eotaxin Level In Chronic Kidney Disease With Hypertension And No Diabetes (5301_7)
16537,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis)
16539,Peak Expiratory Flow,Phenotype,Peak Expiratory Flow
16542,Contrast Sensitivity,Phenotype,Contrast Sensitivity
16544,Type 2 Diabetes,Phenotype,Type 2 Diabetes
16546,Nonsyndromic Cleft Lip With Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Cleft Palate
16548,Worry,Phenotype,Worry
16550,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels,Phenotype,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels
16553,Apolipoprotein A1 Levels,Phenotype,Apolipoprotein A1 Levels
16555,Ssc-A On Hla Dr+ Natural Killer,Phenotype,Ssc-A On Hla Dr+ Natural Killer
16557,Qt Interval,Phenotype,Qt Interval
16561,"Cognitive Ability, Years Of Educational Attainment Or Schizophrenia (Pleiotropy)",Phenotype,"Cognitive Ability, Years Of Educational Attainment Or Schizophrenia (Pleiotropy)"
16563,Phosphatidylethanolamine (18:1_18:2) Levels,Phenotype,Phosphatidylethanolamine (18:1_18:2) Levels
16566,Resilience Score,Phenotype,Resilience Score
16569,Sex Hormone-Binding Globulin Levels,Phenotype,Sex Hormone-Binding Globulin Levels
16573,Laryngeal Squamous Cell Carcinoma,Phenotype,Laryngeal Squamous Cell Carcinoma
16575,Left-handedness,Phenotype,Left-handedness
16578,Diacylglycerol(36:3)_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol(36:3)_[M+H-H2O]1+ Levels
16581,Retinal Detachment Or Retinal Break,Phenotype,Retinal Detachment Or Retinal Break
16583,Myopia,Phenotype,Myopia
16588,Phosphatidylcholines (36:4)B Levels,Phenotype,Phosphatidylcholines (36:4)B Levels
16590,Vaginal Microbiome Metacyc Pathway (Pwy-6397|Mycolyl-Arabinogalactan-Peptidoglycan Complex Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6397|Mycolyl-Arabinogalactan-Peptidoglycan Complex Biosynthesis)
16592,Lung Function (Fvc),Phenotype,Lung Function (Fvc)
16594,Metabolite Peak Levels (Qi10664),Phenotype,Metabolite Peak Levels (Qi10664)
16597,Jt Interval,Phenotype,Jt Interval
16600,Mean Corpuscular Hemoglobin,Phenotype,Mean Corpuscular Hemoglobin
16603,Lymphocyte Count,Phenotype,Lymphocyte Count
16605,Alcohol Consumption (Drinks Per Week) (Mtag),Phenotype,Alcohol Consumption (Drinks Per Week) (Mtag)
16608,Educational Attainment (Years Of Education),Phenotype,Educational Attainment (Years Of Education)
16610,Leprosy,Phenotype,Leprosy
16614,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583),Phenotype,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583)
16616,Creatinine Levels,Phenotype,Creatinine Levels
16618,Depression,Phenotype,Depression
16625,F-Oily Fish Liking (Derived Food-Liking Factor),Phenotype,F-Oily Fish Liking (Derived Food-Liking Factor)
16627,Malaria,Phenotype,Malaria
16629,Homa-B (Corrected For Homa-Ir),Phenotype,Homa-B (Corrected For Homa-Ir)
16631,Asthma Or Allergic Disease (Pleiotropy),Phenotype,Asthma Or Allergic Disease (Pleiotropy)
16633,Neuroticism,Phenotype,Neuroticism
16636,Rheumatoid Arthritis,Phenotype,Rheumatoid Arthritis
16638,Self-Reported Math Ability,Phenotype,Self-Reported Math Ability
16640,Body Mass Index X Other Green Vegetables (Green Pepper And Green Beans) Consumption Interaction,Phenotype,Body Mass Index X Other Green Vegetables (Green Pepper And Green Beans) Consumption Interaction
16643,Major Depressive Disorder,Phenotype,Major Depressive Disorder
16645,Interleukin-1 Receptor-Associated Kinase 4 Levels,Phenotype,Interleukin-1 Receptor-Associated Kinase 4 Levels
16647,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7),Phenotype,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7)
16649,Circulating Docosahexaenoic Acid Levels,Phenotype,Circulating Docosahexaenoic Acid Levels
16651,Amygnuclei Lh Volume Lateral-Nucleus,Phenotype,Amygnuclei Lh Volume Lateral-Nucleus
16654,Breast Size,Phenotype,Breast Size
16656,Obesity (Early Onset Extreme),Phenotype,Obesity (Early Onset Extreme)
16658,Hypertension,Phenotype,Hypertension
16660,Whole Body Fat Free Mass (Ukb Data Field 23101),Phenotype,Whole Body Fat Free Mass (Ukb Data Field 23101)
16665,Cd163/Msr1 Protein Level Ratio,Phenotype,Cd163/Msr1 Protein Level Ratio
16667,Prostate-Specific Antigen Levels,Phenotype,Prostate-Specific Antigen Levels
16671,"Caffeine Metabolism (Plasma 1,7-Dimethylxanthine (Paraxanthine) To 1,3,7-Trimethylxanthine (Caffeine) Ratio)",Phenotype,"Caffeine Metabolism (Plasma 1,7-Dimethylxanthine (Paraxanthine) To 1,3,7-Trimethylxanthine (Caffeine) Ratio)"
16676,Bioavailable Testosterone Levels,Phenotype,Bioavailable Testosterone Levels
16679,Cerebral Microbleeds,Phenotype,Cerebral Microbleeds
16681,Cervical Cancer,Phenotype,Cervical Cancer
16683,O-Cresol Sulfate Levels In Elite Athletes,Phenotype,O-Cresol Sulfate Levels In Elite Athletes
16685,Waist-Hip Ratio,Phenotype,Waist-Hip Ratio
16687,Plasma X-22162 Levels In Chronic Kidney Disease,Phenotype,Plasma X-22162 Levels In Chronic Kidney Disease
16690,Global Electrical Heterogeneity Phenotypes,Phenotype,Global Electrical Heterogeneity Phenotypes
16692,Memory Decline In Impaired Cognition,Phenotype,Memory Decline In Impaired Cognition
16696,Ornithine Levels,Phenotype,Ornithine Levels
16698,Advanced Age-Related Macular Degeneration,Phenotype,Advanced Age-Related Macular Degeneration
16700,Cholelithiasis (Ukb Data Field 20002_1162),Phenotype,Cholelithiasis (Ukb Data Field 20002_1162)
16703,Fish- And Plant-Related Diet,Phenotype,Fish- And Plant-Related Diet
16705,Breast Cancer (Survival),Phenotype,Breast Cancer (Survival)
16707,Left Colon Colorectal Cancer (Peritoneal Metastasis Vs No Metastasis),Phenotype,Left Colon Colorectal Cancer (Peritoneal Metastasis Vs No Metastasis)
16710,Fasting Plasma Glycodeoxycholate 3-O-Glucuronide Concentration,Phenotype,Fasting Plasma Glycodeoxycholate 3-O-Glucuronide Concentration
16713,Direct Bilirubin Levels,Phenotype,Direct Bilirubin Levels
16715,Diverticular Disease,Phenotype,Diverticular Disease
16717,Pr Interval,Phenotype,Pr Interval
16719,Serum Levels Of Protein Fn1,Phenotype,Serum Levels Of Protein Fn1
16721,Central Corneal Thickness,Phenotype,Central Corneal Thickness
16723,Depressive Symptoms,Phenotype,Depressive Symptoms
16725,Follistatin-Related Protein 3 Levels,Phenotype,Follistatin-Related Protein 3 Levels
16728,Facial Morphology,Phenotype,Facial Morphology
16730,Platelet-To-Lymphocyte Ratio,Phenotype,Platelet-To-Lymphocyte Ratio
16732,Migraine (Mtag),Phenotype,Migraine (Mtag)
16736,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index),Phenotype,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index)
16739,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
16742,Brain Shape (Segment 80),Phenotype,Brain Shape (Segment 80)
16745,Heart Rate Response To Exercise,Phenotype,Heart Rate Response To Exercise
16751,Facial Morphology (Segment 7),Phenotype,Facial Morphology (Segment 7)
16753,O-Sulfo-L-Tyrosine Levels,Phenotype,O-Sulfo-L-Tyrosine Levels
16755,Cognitive Performance (Mtag),Phenotype,Cognitive Performance (Mtag)
16758,Colec12/Tafa5 Protein Level Ratio,Phenotype,Colec12/Tafa5 Protein Level Ratio
16761,Retinal Arteriolar Tortuosity,Phenotype,Retinal Arteriolar Tortuosity
16763,Reticulocyte Fraction Of Red Cells,Phenotype,Reticulocyte Fraction Of Red Cells
16766,Gut Microbiota Abundance (K_Bacteria.P_Actinobacteria.C_Actinobacteria.O_Bifidobacteriales.F_Bifidobacteriaceae.G_Bifidobacterium.S_Bifidobacterium_Adolescentis),Phenotype,Gut Microbiota Abundance (K_Bacteria.P_Actinobacteria.C_Actinobacteria.O_Bifidobacteriales.F_Bifidobacteriaceae.G_Bifidobacterium.S_Bifidobacterium_Adolescentis)
16768,General Cognitive Ability,Phenotype,General Cognitive Ability
16770,Total Bilirubin Levels In Hiv-1 Infection,Phenotype,Total Bilirubin Levels In Hiv-1 Infection
16772,Gestational Age At Birth (Child Effect),Phenotype,Gestational Age At Birth (Child Effect)
16774,Methoxychlor Levels,Phenotype,Methoxychlor Levels
16776,Monocyte Count,Phenotype,Monocyte Count
16779,Phospholipid Levels In Very Large Hdl,Phenotype,Phospholipid Levels In Very Large Hdl
16782,Ocular Sarcoidosis In Sarcoidosis,Phenotype,Ocular Sarcoidosis In Sarcoidosis
16785,COVID-19,Phenotype,COVID-19
16789,Glycated Hemoglobin Levels,Phenotype,Glycated Hemoglobin Levels
16791,Alcohol Dependence (Dominant Genetic Model),Phenotype,Alcohol Dependence (Dominant Genetic Model)
16794,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire,Phenotype,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire
16796,Response To Methotrexate In Juvenile Idiopathic Arthritis,Phenotype,Response To Methotrexate In Juvenile Idiopathic Arthritis
16798,Deliberate Self-Harm,Phenotype,Deliberate Self-Harm
16801,Memory Decline,Phenotype,Memory Decline
16803,Neurofibrillary Tangles (Snp X Snp Interaction),Phenotype,Neurofibrillary Tangles (Snp X Snp Interaction)
16808,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621),Phenotype,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621)
16810,Overall Survival In Er Negative Breast Cancer,Phenotype,Overall Survival In Er Negative Breast Cancer
16812,"Allergic Disease (Asthma, Hay Fever And/Or Eczema) (Multivariate Analysis)",Phenotype,"Allergic Disease (Asthma, Hay Fever And/Or Eczema) (Multivariate Analysis)"
16814,Gall Stone Disease Or Coronary Artery Disease,Phenotype,Gall Stone Disease Or Coronary Artery Disease
16816,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels,Phenotype,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels
16818,Body Mass Index And Coronary Artery Disease (Pairwise),Phenotype,Body Mass Index And Coronary Artery Disease (Pairwise)
16820,Heart Failure,Phenotype,Heart Failure
16827,Interferon-Related Traits,Phenotype,Interferon-Related Traits
16829,Mosquito Bite Size,Phenotype,Mosquito Bite Size
16831,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35),Phenotype,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35)
16835,Cytochrome P450 3A4 Levels,Phenotype,Cytochrome P450 3A4 Levels
16837,Drinks Per Week,Phenotype,Drinks Per Week
16840,Antipsychotic-Induced Ldl-Cholesterol Change In Schizophrenia (4-Week),Phenotype,Antipsychotic-Induced Ldl-Cholesterol Change In Schizophrenia (4-Week)
16842,Heart Rate In Heart Failure With Reduced Ejection Fraction,Phenotype,Heart Rate In Heart Failure With Reduced Ejection Fraction
16844,Monocyte Forward Scatter Distribution Width,Phenotype,Monocyte Forward Scatter Distribution Width
16846,Blood Urea Nitrogen Levels,Phenotype,Blood Urea Nitrogen Levels
16848,Cold Induced Vasodilation,Phenotype,Cold Induced Vasodilation
16850,Asthma (Childhood Onset),Phenotype,Asthma (Childhood Onset)
16852,Seropositivity For Bartonella Henselae Peptide (Agilent_237188),Phenotype,Seropositivity For Bartonella Henselae Peptide (Agilent_237188)
16856,Non-Melanoma Skin Cancer,Phenotype,Non-Melanoma Skin Cancer
16860,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis)
16864,Alzheimer'S Disease Or Educational Attainment (Pleiotropy),Phenotype,Alzheimer'S Disease Or Educational Attainment (Pleiotropy)
16867,Intraocular Pressure (Confirmatory Factor Analysis Factor 26),Phenotype,Intraocular Pressure (Confirmatory Factor Analysis Factor 26)
16869,Household Income (Mtag),Phenotype,Household Income (Mtag)
16871,Seropositivity For Plasmodium Falciparum Peptide (Twist_36885),Phenotype,Seropositivity For Plasmodium Falciparum Peptide (Twist_36885)
16873,Concentration Of Small Ldl Particles,Phenotype,Concentration Of Small Ldl Particles
16877,Ceramide Levels,Phenotype,Ceramide Levels
16879,Fractalkine Levels,Phenotype,Fractalkine Levels
16882,Total Cholesterol In Medium Ldl,Phenotype,Total Cholesterol In Medium Ldl
16886,Protein Delta Homolog 1:Extracellular Domain Levels,Phenotype,Protein Delta Homolog 1:Extracellular Domain Levels
16889,Essential Hypertension (Time To Event),Phenotype,Essential Hypertension (Time To Event)
16891,Color Vision Defects (Deutan-Protan),Phenotype,Color Vision Defects (Deutan-Protan)
16893,Pancreatic Cancer,Phenotype,Pancreatic Cancer
16898,Highest Math Class Taken,Phenotype,Highest Math Class Taken
16901,Resistance To Covid-19 Infection (Exposed Negative Vs Positive),Phenotype,Resistance To Covid-19 Infection (Exposed Negative Vs Positive)
16904,Corneal Curvature,Phenotype,Corneal Curvature
16906,Free Cholesterol In Medium Ldl,Phenotype,Free Cholesterol In Medium Ldl
16912,FVC,Phenotype,FVC
16916,Cholesterol In Small Vldl (Ukb Data Field 23512),Phenotype,Cholesterol In Small Vldl (Ukb Data Field 23512)
16920,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour)
16922,Medication Use (Antihypertensives),Phenotype,Medication Use (Antihypertensives)
16924,Waist-Hip Index,Phenotype,Waist-Hip Index
16925,Basophil Count,Phenotype,Basophil Count
16928,Stable Warfarin Dose,Phenotype,Stable Warfarin Dose
16930,Beans Liking,Phenotype,Beans Liking
16933,Bone Mineral Density,Phenotype,Bone Mineral Density
16935,Dorsomedial Frontal Area (Unadjusted For Global Measures),Phenotype,Dorsomedial Frontal Area (Unadjusted For Global Measures)
16938,Caspase Recruitment Domain-Containing Protein 18 Levels,Phenotype,Caspase Recruitment Domain-Containing Protein 18 Levels
16940,Pcdh17/Ptprm Protein Level Ratio,Phenotype,Pcdh17/Ptprm Protein Level Ratio
16943,Igg Glycosylation,Phenotype,Igg Glycosylation
16946,Educational Attainment (Mtag),Phenotype,Educational Attainment (Mtag)
16948,Verbal Learning,Phenotype,Verbal Learning
16950,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag),Phenotype,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag)
16952,Reticulocyte Count,Phenotype,Reticulocyte Count
16954,"5Alpha-Pregnan-3Beta,20Alpha-Diol Monosulfate (2) Levels In Elite Athletes",Phenotype,"5Alpha-Pregnan-3Beta,20Alpha-Diol Monosulfate (2) Levels In Elite Athletes"
16957,Gestational Thrombocytopenia,Phenotype,Gestational Thrombocytopenia
16960,Trafficking Protein Particle Complex Subunit 4 Levels,Phenotype,Trafficking Protein Particle Complex Subunit 4 Levels
16963,Total Lipids In Medium Vldl,Phenotype,Total Lipids In Medium Vldl
16965,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction),Phenotype,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction)
16967,Triglycerides To Total Lipids Ratio In Large Ldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Ldl
16969,Dementia,Phenotype,Dementia
16971,Covid-19 (Covid Vs Negative),Phenotype,Covid-19 (Covid Vs Negative)
16976,Regular Attendance At A Gym Or Sports Club,Phenotype,Regular Attendance At A Gym Or Sports Club
16979,High Light Scatter Reticulocyte Count,Phenotype,High Light Scatter Reticulocyte Count
16981,Self-Reported Allergy,Phenotype,Self-Reported Allergy
16983,Crisps Liking,Phenotype,Crisps Liking
16985,Venous Thromboembolism (Snp X Snp Interaction),Phenotype,Venous Thromboembolism (Snp X Snp Interaction)
16987,Response To Cognitive-Behavioural Therapy In Anxiety Disorder,Phenotype,Response To Cognitive-Behavioural Therapy In Anxiety Disorder
16991,Platelet Distribution Width,Phenotype,Platelet Distribution Width
16999,Pentraxin-Related Protein Ptx3 Levels,Phenotype,Pentraxin-Related Protein Ptx3 Levels
17002,X-12244--N-Acetylcarnosine Levels,Phenotype,X-12244--N-Acetylcarnosine Levels
17005,Physiological Traits,Phenotype,Physiological Traits
17008,Cannabis Use Disorder,Phenotype,Cannabis Use Disorder
17012,Transcription Initiation Factor Tfiid Subunit 10 Levels,Phenotype,Transcription Initiation Factor Tfiid Subunit 10 Levels
17014,Fasting Insulin Z-Score (>50Th Percentile),Phenotype,Fasting Insulin Z-Score (>50Th Percentile)
17016,Cigarettes Smoked Per Day,Phenotype,Cigarettes Smoked Per Day
17025,Facial Morphology (Segment 14),Phenotype,Facial Morphology (Segment 14)
17028,Suicide Attempts,Phenotype,Suicide Attempts
17032,Pediatric Bone Mineral Content (Radius),Phenotype,Pediatric Bone Mineral Content (Radius)
17034,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628),Phenotype,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628)
17036,Femur Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,Femur Bone Mineral Density X Serum Urate Levels Interaction
17041,Acute Radiotoxicity In Prostate Cancer,Phenotype,Acute Radiotoxicity In Prostate Cancer
17043,Shoulder Impingement Syndrome,Phenotype,Shoulder Impingement Syndrome
17046,Post Bronchodilator Fev1,Phenotype,Post Bronchodilator Fev1
17048,Interleukin-17 Receptor D Levels,Phenotype,Interleukin-17 Receptor D Levels
17054,Covid-19 (Hospitalized Vs Not Hospitalized),Phenotype,Covid-19 (Hospitalized Vs Not Hospitalized)
17056,Testosterone Levels X Vegetarianism Interaction,Phenotype,Testosterone Levels X Vegetarianism Interaction
17058,Glucose-Dependent Insulinotropic Peptide Levels,Phenotype,Glucose-Dependent Insulinotropic Peptide Levels
17064,Surgical Knee Osteoarthritis,Phenotype,Surgical Knee Osteoarthritis
17068,Whole Brain Free Water Diffusion (Multivariate Analysis),Phenotype,Whole Brain Free Water Diffusion (Multivariate Analysis)
17070,White Blood Cell Count (Basophil),Phenotype,White Blood Cell Count (Basophil)
17072,Serum Alkaline Phosphatase Levels,Phenotype,Serum Alkaline Phosphatase Levels
17074,Bipolar Disorder,Phenotype,Bipolar Disorder
17076,Optic Disc Size,Phenotype,Optic Disc Size
17078,Body Mass Index (Change Over Time),Phenotype,Body Mass Index (Change Over Time)
17080,Caproate (6:0) Levels,Phenotype,Caproate (6:0) Levels
17083,3-Hydroxyisobutyrate Levels In Elite Athletes,Phenotype,3-Hydroxyisobutyrate Levels In Elite Athletes
17085,Alzheimer'S Disease With Visuospatial Domain Impairment,Phenotype,Alzheimer'S Disease With Visuospatial Domain Impairment
17087,Hdl Cholesterol Levels,Phenotype,Hdl Cholesterol Levels
17090,X-24947 Levels,Phenotype,X-24947 Levels
17093,Response To Metformin (Ic50),Phenotype,Response To Metformin (Ic50)
17095,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 1 Levels,Phenotype,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 1 Levels
17097,C-Reactive Protein Levels (Mtag),Phenotype,C-Reactive Protein Levels (Mtag)
17104,Alzheimer'S Disease (Cognitive Decline),Phenotype,Alzheimer'S Disease (Cognitive Decline)
17106,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score),Phenotype,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score)
17110,Osteoarthritis,Phenotype,Osteoarthritis
17111,Deep White Matter Hyperintensities,Phenotype,Deep White Matter Hyperintensities
17113,Plateletcrit,Phenotype,Plateletcrit
17115,Sphingomyelin(32:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(32:1)_[M+H]1+ Levels
17120,Brain Morphology (Min-P),Phenotype,Brain Morphology (Min-P)
17125,Decanoylcarnitine Levels,Phenotype,Decanoylcarnitine Levels
17130,Response To Hepatitis C Treatment,Phenotype,Response To Hepatitis C Treatment
17132,Ischemic Stroke (Cardioembolic),Phenotype,Ischemic Stroke (Cardioembolic)
17134,Serum Urea Levels,Phenotype,Serum Urea Levels
17136,Migraine,Phenotype,Migraine
17138,"Glycosyl Ceramide (D18:1/20:0, D16:1/22:0) Levels",Phenotype,"Glycosyl Ceramide (D18:1/20:0, D16:1/22:0) Levels"
17141,Eosinophil Forward Scatter,Phenotype,Eosinophil Forward Scatter
17143,Endometriosis,Phenotype,Endometriosis
17145,Hemoglobin Concentration,Phenotype,Hemoglobin Concentration
17148,Multimerin-2 Levels (Mmrn2.11895.21.3),Phenotype,Multimerin-2 Levels (Mmrn2.11895.21.3)
17151,Testican-3 Levels,Phenotype,Testican-3 Levels
17153,Brain Volume In Infants (Grey Matter),Phenotype,Brain Volume In Infants (Grey Matter)
17156,Erbin/Lat2 Protein Level Ratio,Phenotype,Erbin/Lat2 Protein Level Ratio
17158,Reticulocyte Side Fluorescence,Phenotype,Reticulocyte Side Fluorescence
17160,Dental Caries,Phenotype,Dental Caries
17163,Protocadherin-10:Extracellular Domain Levels,Phenotype,Protocadherin-10:Extracellular Domain Levels
17165,Chronic Obstructive Pulmonary Disease,Phenotype,Chronic Obstructive Pulmonary Disease
17168,"Estimated Glomerular Filtration Rate (Creatinine, Cystatin C)",Phenotype,"Estimated Glomerular Filtration Rate (Creatinine, Cystatin C)"
17170,Adolescent Idiopathic Scoliosis,Phenotype,Adolescent Idiopathic Scoliosis
17172,Covid-19 (Critical Illness Vs Population),Phenotype,Covid-19 (Critical Illness Vs Population)
17177,Growth-Regulated Alpha Protein Levels,Phenotype,Growth-Regulated Alpha Protein Levels
17179,Cognitive Performance (Attention) (Longitudinal),Phenotype,Cognitive Performance (Attention) (Longitudinal)
17182,Cortical Thickness,Phenotype,Cortical Thickness
17186,Vitamin D-Binding Protein Levels,Phenotype,Vitamin D-Binding Protein Levels
17188,Allergic Sensitization,Phenotype,Allergic Sensitization
17190,Nk-Cell Telomere Length,Phenotype,Nk-Cell Telomere Length
17192,Estimated Glomerular Filtration Rate,Phenotype,Estimated Glomerular Filtration Rate
17194,Glucose Levels,Phenotype,Glucose Levels
17196,Diffuse Plaques (Snp X Snp Interaction),Phenotype,Diffuse Plaques (Snp X Snp Interaction)
17198,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test)
17199,Venous Thromboembolism,Phenotype,Venous Thromboembolism
17202,Multi-Trait Sex Score,Phenotype,Multi-Trait Sex Score
17205,Personality Traits Or Cognitive Traits (Multivariate Analysis),Phenotype,Personality Traits Or Cognitive Traits (Multivariate Analysis)
17208,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic))
17212,Composite Immunoglobulin Trait (Igg/Igm),Phenotype,Composite Immunoglobulin Trait (Igg/Igm)
17214,Monohexosylceramide (D16:1/18:0) Levels,Phenotype,Monohexosylceramide (D16:1/18:0) Levels
17216,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction),Phenotype,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction)
17218,Smooth-Surface Caries,Phenotype,Smooth-Surface Caries
17220,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density),Phenotype,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density)
17222,Sterol Ester (27:1/18:2) Levels,Phenotype,Sterol Ester (27:1/18:2) Levels
17225,Rectal Cancer,Phenotype,Rectal Cancer
17227,Uveal Melanoma (Tnm Stage 3 Or 4),Phenotype,Uveal Melanoma (Tnm Stage 3 Or 4)
17229,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels,Phenotype,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels
17233,Enterococcaceae Abundance In Stool,Phenotype,Enterococcaceae Abundance In Stool
17236,Phospholipids In Small Vldl,Phenotype,Phospholipids In Small Vldl
17238,Atrial Fibrillation (Mtag),Phenotype,Atrial Fibrillation (Mtag)
17241,Efna4/Scarb2 Protein Level Ratio,Phenotype,Efna4/Scarb2 Protein Level Ratio
17243,Eczema,Phenotype,Eczema
17245,Blond Vs. Brown/Black Hair Color,Phenotype,Blond Vs. Brown/Black Hair Color
17253,Limited Cutaneous Systemic Scleroderma,Phenotype,Limited Cutaneous Systemic Scleroderma
17255,Cigarettes Smoked Per Day (Mtag),Phenotype,Cigarettes Smoked Per Day (Mtag)
17257,Abdominal Aortic Aneurysm,Phenotype,Abdominal Aortic Aneurysm
17259,Estimated Glomerular Filtration Rate (Creatinine),Phenotype,Estimated Glomerular Filtration Rate (Creatinine)
17263,Systolic Blood Pressure (Bmi Unadjusted),Phenotype,Systolic Blood Pressure (Bmi Unadjusted)
17265,Diisocyanate-Induced Asthma,Phenotype,Diisocyanate-Induced Asthma
17269,Baseline Memory In Impaired Cognition,Phenotype,Baseline Memory In Impaired Cognition
17271,Principal Component-Derived Dietary Pattern 1,Phenotype,Principal Component-Derived Dietary Pattern 1
17274,Urine X-11612 Levels In Chronic Kidney Disease,Phenotype,Urine X-11612 Levels In Chronic Kidney Disease
17277,Aspartate Aminotransferase Levels,Phenotype,Aspartate Aminotransferase Levels
17279,Eosinophil-Derived Neurotoxin Levels,Phenotype,Eosinophil-Derived Neurotoxin Levels
17282,Chronotype,Phenotype,Chronotype
17284,Itgb1Bp2/Tia1 Protein Level Ratio,Phenotype,Itgb1Bp2/Tia1 Protein Level Ratio
17286,Allergy,Phenotype,Allergy
17289,Phosphatidylglycerol(32:1)_[M+Oac]1- Levels,Phenotype,Phosphatidylglycerol(32:1)_[M+Oac]1- Levels
17291,Night Sleep Phenotypes,Phenotype,Night Sleep Phenotypes
17296,Suicide Attempt Severity In Mood Disorders,Phenotype,Suicide Attempt Severity In Mood Disorders
17301,Metabolite Levels,Phenotype,Metabolite Levels
17303,Sphingolipid Levels,Phenotype,Sphingolipid Levels
17306,Endrin Levels,Phenotype,Endrin Levels
17309,Parkinson'S Disease,Phenotype,Parkinson'S Disease
17314,Vwf Levels,Phenotype,Vwf Levels
17317,Cystatin C Levels,Phenotype,Cystatin C Levels
17319,Arachidonoylcarnitine (C20:4) Levels,Phenotype,Arachidonoylcarnitine (C20:4) Levels
17323,Cognitive Decline Rate In Late Mild Cognitive Impairment,Phenotype,Cognitive Decline Rate In Late Mild Cognitive Impairment
17326,Nicotine Dependence,Phenotype,Nicotine Dependence
17328,Blood And Toenail Selenium Levels,Phenotype,Blood And Toenail Selenium Levels
17330,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,Phenotype,Lysophosphatidylethanolamine (16:0) [Sn1] Levels
17332,Hars1/Mesd Protein Level Ratio,Phenotype,Hars1/Mesd Protein Level Ratio
17336,Autism Spectrum Disorder Or Schizophrenia,Phenotype,Autism Spectrum Disorder Or Schizophrenia
17338,Cleft Lip With Or Without Cleft Palate,Phenotype,Cleft Lip With Or Without Cleft Palate
17340,Waist Circumference Adjusted For Bmi In Active Individuals,Phenotype,Waist Circumference Adjusted For Bmi In Active Individuals
17342,Major Depressive Disorder Or Stress-Related Disorder,Phenotype,Major Depressive Disorder Or Stress-Related Disorder
17344,Concentration Of Large Vldl Particles,Phenotype,Concentration Of Large Vldl Particles
17346,Mortality In Sepsis,Phenotype,Mortality In Sepsis
17351,Rs-Warfarin Levels,Phenotype,Rs-Warfarin Levels
17357,Sum Eosinophil Basophil Counts,Phenotype,Sum Eosinophil Basophil Counts
17362,Corneal Astigmatism,Phenotype,Corneal Astigmatism
17364,White Matter Microstructure (Radial Diusivities),Phenotype,White Matter Microstructure (Radial Diusivities)
17370,Cd5/Il16 Protein Level Ratio,Phenotype,Cd5/Il16 Protein Level Ratio
17373,Free Testosterone Levels,Phenotype,Free Testosterone Levels
17375,Risk-Taking Tendency (4-Domain Principal Component Model),Phenotype,Risk-Taking Tendency (4-Domain Principal Component Model)
17382,Leisure Sedentary Behaviour (Television Watching),Phenotype,Leisure Sedentary Behaviour (Television Watching)
17384,Total Testosterone Levels,Phenotype,Total Testosterone Levels
17388,Cortical Surface Area,Phenotype,Cortical Surface Area
17390,Free Cholesterol To Total Lipids Ratio In Small Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Ldl
17392,Hair Color,Phenotype,Hair Color
17394,Post Bronchodilator Fev1/Fvc Ratio In Copd,Phenotype,Post Bronchodilator Fev1/Fvc Ratio In Copd
17397,Prostate Cancer,Phenotype,Prostate Cancer
17399,C-Reactive Protein Levels,Phenotype,C-Reactive Protein Levels
17402,Free Cholesterol To Total Lipids Ratio In Medium Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Medium Ldl
17404,Medication Use For Hypertension (Number Of Purchases),Phenotype,Medication Use For Hypertension (Number Of Purchases)
17406,Renal Function And Chronic Kidney Disease,Phenotype,Renal Function And Chronic Kidney Disease
17411,Proinsulin Levels,Phenotype,Proinsulin Levels
17413,Cortical Thickness (Mostest),Phenotype,Cortical Thickness (Mostest)
17415,Shingles,Phenotype,Shingles
17417,Brain Morphology (Mostest),Phenotype,Brain Morphology (Mostest)
17419,FEV1,Phenotype,FEV1
17421,Inhibitory Control,Phenotype,Inhibitory Control
17423,Systemic Sclerosis,Phenotype,Systemic Sclerosis
17426,Precentral Gyrus Volume,Phenotype,Precentral Gyrus Volume
17432,Body Surface Area,Phenotype,Body Surface Area
17434,Diacylglycerol_38:5_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:5_[M+H-H2O]1+ Levels
17436,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp),Phenotype,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp)
17442,Handedness In Dyslexia,Phenotype,Handedness In Dyslexia
17445,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl
17447,Free Androgen Index,Phenotype,Free Androgen Index
17450,Essential Tremor,Phenotype,Essential Tremor
17454,Periodontitis (Mean Pal),Phenotype,Periodontitis (Mean Pal)
17456,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488),Phenotype,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488)
17458,Excessive Daytime Sleepiness,Phenotype,Excessive Daytime Sleepiness
17460,Gastric Cancer,Phenotype,Gastric Cancer
17464,Morning Vs. Evening Chronotype,Phenotype,Morning Vs. Evening Chronotype
17467,Alkenylphosphatidylethanolamine (P-20:0/18:2) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-20:0/18:2) Levels
17469,Cd79B/Tnfrsf13B Protein Level Ratio,Phenotype,Cd79B/Tnfrsf13B Protein Level Ratio
17471,Familial Lung Adenocarcinoma,Phenotype,Familial Lung Adenocarcinoma
17473,Atopic Asthma,Phenotype,Atopic Asthma
17475,Cortical Thickness (Min-P),Phenotype,Cortical Thickness (Min-P)
17478,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome,Phenotype,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome
17481,Hip Index,Phenotype,Hip Index
17483,Emotional Lability In Attention Deficit Hyperactivity Disorder,Phenotype,Emotional Lability In Attention Deficit Hyperactivity Disorder
17486,Cholesteryl Esters To Total Lipids Ratio In Small Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Hdl
17488,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis),Phenotype,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis)
17490,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma,Phenotype,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma
17493,Circulating Chromogranin Peptide Levels,Phenotype,Circulating Chromogranin Peptide Levels
17495,Sunburns,Phenotype,Sunburns
17498,Micb_Mica/Tek Protein Level Ratio,Phenotype,Micb_Mica/Tek Protein Level Ratio
17501,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy)
17506,"Alzheimer'S Disease, Proxy Alzheimer'S Disease Or Related Dementias",Phenotype,"Alzheimer'S Disease, Proxy Alzheimer'S Disease Or Related Dementias"
17509,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),Phenotype,Type 2 Diabetes Or Prostate Cancer (Pleiotropy)
17512,Brain Shape (Segment 1),Phenotype,Brain Shape (Segment 1)
17515,Height (Standard Gwa),Phenotype,Height (Standard Gwa)
17521,Type 1 Diabetes (Age At Diagnosis),Phenotype,Type 1 Diabetes (Age At Diagnosis)
17523,Idp Dmri Probtrackx Icvf Ifo L,Phenotype,Idp Dmri Probtrackx Icvf Ifo L
17525,Atopic Dermatitis,Phenotype,Atopic Dermatitis
17527,Adventurousness,Phenotype,Adventurousness
17529,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease,Phenotype,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease
17531,Idp Dmri Probtrackx Icvf Cgh R,Phenotype,Idp Dmri Probtrackx Icvf Cgh R
17534,Cutaneous Melanoma (Mtag),Phenotype,Cutaneous Melanoma (Mtag)
17541,Ldl Cholesterol X Physical Activity Interaction (2Df Test),Phenotype,Ldl Cholesterol X Physical Activity Interaction (2Df Test)
17542,White Matter Microstructure (Fractional Anisotropy),Phenotype,White Matter Microstructure (Fractional Anisotropy)
17544,Mean Reticulocyte Volume,Phenotype,Mean Reticulocyte Volume
17546,Itch Intensity From Mosquito Bite Adjusted By Bite Size,Phenotype,Itch Intensity From Mosquito Bite Adjusted By Bite Size
17548,Complement Component C8 Levels,Phenotype,Complement Component C8 Levels
17551,Bone Mineral Density (Spine),Phenotype,Bone Mineral Density (Spine)
17554,Concentration Of Chylomicrons And Extremely Large Vldl Particles,Phenotype,Concentration Of Chylomicrons And Extremely Large Vldl Particles
17556,Covid-19 (Hospitalized Covid Vs Population),Phenotype,Covid-19 (Hospitalized Covid Vs Population)
17558,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure),Phenotype,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure)
17561,Psoriasis,Phenotype,Psoriasis
17563,Inguinal Hernia,Phenotype,Inguinal Hernia
17568,Plasma X-12689 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12689 Levels In Chronic Kidney Disease
17572,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944)
17574,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50),Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50)
17576,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp),Phenotype,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp)
17579,Response To Phenytoin In Focal Epilepsy,Phenotype,Response To Phenytoin In Focal Epilepsy
17581,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512)
17588,Respiratory Disease (Confirmatory Factor Analysis Factor 11),Phenotype,Respiratory Disease (Confirmatory Factor Analysis Factor 11)
17591,Left Ventricle Wall Thickness,Phenotype,Left Ventricle Wall Thickness
17593,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy),Phenotype,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy)
17598,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction,Phenotype,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction
17600,Triglyceride Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Triglyceride Levels In Chylomicrons And Extremely Large Vldl
17604,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze),Phenotype,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze)
17606,Orofacial Clefts,Phenotype,Orofacial Clefts
17609,Rbc Levels Of Pyruvate (Um),Phenotype,Rbc Levels Of Pyruvate (Um)
17611,Neutrophil Percentage Of Granulocytes,Phenotype,Neutrophil Percentage Of Granulocytes
17613,Meat-Related Diet,Phenotype,Meat-Related Diet
17616,Medication Use (Agents Acting On The Renin-Angiotensin System),Phenotype,Medication Use (Agents Acting On The Renin-Angiotensin System)
17618,Pemphigus Vulgaris,Phenotype,Pemphigus Vulgaris
17622,Fev1 Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fev1 Or Irritable Bowel Syndrome (Pleiotropy)
17625,Idp Dmri Tbss L2 Corticospinal Tract R,Phenotype,Idp Dmri Tbss L2 Corticospinal Tract R
17634,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model)
17636,Triglyceride Levels (Mtag),Phenotype,Triglyceride Levels (Mtag)
17638,Total Lipid Levels In Small Hdl,Phenotype,Total Lipid Levels In Small Hdl
17640,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate),Phenotype,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate)
17645,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis)
17647,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy)
17650,Colorectal Cancer X Estrogen Hormone Therapy Interaction,Phenotype,Colorectal Cancer X Estrogen Hormone Therapy Interaction
17653,Ldl Cholesterol Levels In Current Drinkers,Phenotype,Ldl Cholesterol Levels In Current Drinkers
17656,Color Vision Defects (Tritan),Phenotype,Color Vision Defects (Tritan)
17660,"Covid-19 (Hospitalized Vs Tested, Not Hospitalized)",Phenotype,"Covid-19 (Hospitalized Vs Tested, Not Hospitalized)"
17662,Lymphocyte Forward Scatter,Phenotype,Lymphocyte Forward Scatter
17664,Cardiometabolic Multimorbidity,Phenotype,Cardiometabolic Multimorbidity
17666,Systemic Lupus Erythematosus,Phenotype,Systemic Lupus Erythematosus
17670,Lipoprotein (A) Levels,Phenotype,Lipoprotein (A) Levels
17673,Testasv_20 (Phascolarctobacterium) Abundance,Phenotype,Testasv_20 (Phascolarctobacterium) Abundance
17678,Body Fat Distribution (Leg Fat Ratio),Phenotype,Body Fat Distribution (Leg Fat Ratio)
17680,Fvc Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fvc Or Irritable Bowel Syndrome (Pleiotropy)
17683,Cholesterol To Total Lipids Ratio In Very Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Very Large Hdl
17685,Cholesteryl Ester (20:3) Levels,Phenotype,Cholesteryl Ester (20:3) Levels
17689,White Matter Microstructure (Mode Of Anisotropy),Phenotype,White Matter Microstructure (Mode Of Anisotropy)
17693,Pierre Robin Sequence Endophenotypic Score,Phenotype,Pierre Robin Sequence Endophenotypic Score
17700,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol))
17702,Bmi (Adjusted For Smoking Behaviour),Phenotype,Bmi (Adjusted For Smoking Behaviour)
17705,High-Density Lipoprotein Levels (Mtag),Phenotype,High-Density Lipoprotein Levels (Mtag)
17709,Nasopharyngeal Carcinoma (Snp X Snp Interaction),Phenotype,Nasopharyngeal Carcinoma (Snp X Snp Interaction)
17711,Depression (Broad),Phenotype,Depression (Broad)
17713,Ischemic Stroke In Diabetes Mellitus,Phenotype,Ischemic Stroke In Diabetes Mellitus
17716,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119)
17718,Malignant Lymphoma,Phenotype,Malignant Lymphoma
17722,Red Meat Related Metabolomic Signature,Phenotype,Red Meat Related Metabolomic Signature
17725,Mean Corpuscular Hemoglobin Concentration,Phenotype,Mean Corpuscular Hemoglobin Concentration
17729,Vertex-Wise Cortical Surface Area,Phenotype,Vertex-Wise Cortical Surface Area
17733,Iron Status Biomarkers (Transferrin Levels),Phenotype,Iron Status Biomarkers (Transferrin Levels)
17734,Cd4-Cd8- T Cell Absolute Count,Phenotype,Cd4-Cd8- T Cell Absolute Count
17738,Ovarian Cancer (Mtag),Phenotype,Ovarian Cancer (Mtag)
17740,Refractive Error,Phenotype,Refractive Error
17743,Childhood Wheezing (Late-Onset),Phenotype,Childhood Wheezing (Late-Onset)
17745,Serum Total Protein Levels,Phenotype,Serum Total Protein Levels
17747,F-Small Fish Liking (Derived Food-Liking Factor),Phenotype,F-Small Fish Liking (Derived Food-Liking Factor)
17755,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16),Phenotype,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16)
17757,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels,Phenotype,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels
17760,Pulse Pressure (Bmi Unadjusted),Phenotype,Pulse Pressure (Bmi Unadjusted)
17762,Metabolite Levels (Pyroglutamine),Phenotype,Metabolite Levels (Pyroglutamine)
17767,Mean Spheric Corpuscular Volume,Phenotype,Mean Spheric Corpuscular Volume
17769,Gastroesophageal Reflux Disease,Phenotype,Gastroesophageal Reflux Disease
17773,Total Lipid Levels In Hdl,Phenotype,Total Lipid Levels In Hdl
17778,Medication Use (Calcium Channel Blockers),Phenotype,Medication Use (Calcium Channel Blockers)
17781,Facial Morphology (Profile Nasal Area),Phenotype,Facial Morphology (Profile Nasal Area)
17783,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis)
17786,Gamma Glutamyl Transpeptidase,Phenotype,Gamma Glutamyl Transpeptidase
17788,Free Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Vldl
17791,Schizophrenia Vs Adhd (Ordinary Least Squares (Ols)),Phenotype,Schizophrenia Vs Adhd (Ordinary Least Squares (Ols))
17793,Staphylococcus Aureus Nasal Carriage (Persistent),Phenotype,Staphylococcus Aureus Nasal Carriage (Persistent)
17795,Osteoarthrosis (Time To Event),Phenotype,Osteoarthrosis (Time To Event)
17797,Vaginal Microbiome Relative Abundance (C_Clostridia),Phenotype,Vaginal Microbiome Relative Abundance (C_Clostridia)
17804,"Aspartate Aminotransferase, Cytoplasmic Levels",Phenotype,"Aspartate Aminotransferase, Cytoplasmic Levels"
17807,Total Lipid Levels In Idl,Phenotype,Total Lipid Levels In Idl
17808,Alzheimer'S Disease In Apoe E4+ Carriers,Phenotype,Alzheimer'S Disease In Apoe E4+ Carriers
17810,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27),Phenotype,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27)
17812,Superior Parietal Area (Unadjusted For Global Measures),Phenotype,Superior Parietal Area (Unadjusted For Global Measures)
17814,Education Attainment Or Alcohol Use Disorders,Phenotype,Education Attainment Or Alcohol Use Disorders
17816,Sum Basophil Neutrophil Counts,Phenotype,Sum Basophil Neutrophil Counts
17819,Serum Levels Of Protein Ctnnb1,Phenotype,Serum Levels Of Protein Ctnnb1
17822,Small Nuclear Ribonucleoprotein F Level In Chronic Kidney Disease With Hypertension And No Diabetes (5494_52),Phenotype,Small Nuclear Ribonucleoprotein F Level In Chronic Kidney Disease With Hypertension And No Diabetes (5494_52)
17826,Clopidogrel Active Metabolite Levels,Phenotype,Clopidogrel Active Metabolite Levels
17828,Lat2/Manf Protein Level Ratio,Phenotype,Lat2/Manf Protein Level Ratio
17830,Interferon Gamma Levels,Phenotype,Interferon Gamma Levels
17833,Gallstone Disease,Phenotype,Gallstone Disease
17835,Covid-19 (Severe Respiratory Symptoms Vs Population),Phenotype,Covid-19 (Severe Respiratory Symptoms Vs Population)
17840,Triglycerides In Medium Hdl,Phenotype,Triglycerides In Medium Hdl
17843,Resistant Hypertension,Phenotype,Resistant Hypertension
17846,Bone Mineral Density (Femoral Neck),Phenotype,Bone Mineral Density (Femoral Neck)
17849,Regional Cortical Thickness (Medialorbitofrontal),Phenotype,Regional Cortical Thickness (Medialorbitofrontal)
17852,"Glycosyl Ceramide (D18:2/24:1, D18:1/24:2) Levels In Elite Athletes",Phenotype,"Glycosyl Ceramide (D18:2/24:1, D18:1/24:2) Levels In Elite Athletes"
17855,Eudaimonic Well-Being,Phenotype,Eudaimonic Well-Being
17859,Omega-3 Fatty Acid Levels,Phenotype,Omega-3 Fatty Acid Levels
17863,Inferior Parietal Area (Unadjusted For Global Measures),Phenotype,Inferior Parietal Area (Unadjusted For Global Measures)
17867,Phospholipids In Very Small Vldl,Phenotype,Phospholipids In Very Small Vldl
17870,Facial Morphology (Profile Nasal Angle),Phenotype,Facial Morphology (Profile Nasal Angle)
17873,Serum Phosphate Levels,Phenotype,Serum Phosphate Levels
17876,Vertex-Wise Sulcal Depth,Phenotype,Vertex-Wise Sulcal Depth
17879,Periodontitis (Cdc/Aap),Phenotype,Periodontitis (Cdc/Aap)
17883,Total Body Bone Mineral Density,Phenotype,Total Body Bone Mineral Density
17888,Crtam/Gzma Protein Level Ratio,Phenotype,Crtam/Gzma Protein Level Ratio
17891,Asthma And Cardiovascular Disease,Phenotype,Asthma And Cardiovascular Disease
17893,Hemoglobin,Phenotype,Hemoglobin
17901,Bipolar Disorder Or Ulcerative Colitis (Mtag),Phenotype,Bipolar Disorder Or Ulcerative Colitis (Mtag)
17904,Microfibril-Associated Glycoprotein 4 Levels,Phenotype,Microfibril-Associated Glycoprotein 4 Levels
17906,Right-Hemisphere Somatomotor Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Somatomotor Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity
17909,Alanine Aminotransferase Levels,Phenotype,Alanine Aminotransferase Levels
17912,Serum Levels Of Protein Clec4G,Phenotype,Serum Levels Of Protein Clec4G
17916,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534),Phenotype,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534)
17922,Aseg Lh Volume Cerebellum-Cortex,Phenotype,Aseg Lh Volume Cerebellum-Cortex
17925,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test)
17927,Alcohol Consumption,Phenotype,Alcohol Consumption
17929,Alcoholic Chronic Pancreatitis,Phenotype,Alcoholic Chronic Pancreatitis
17931,"Bone Mineral Density (Paediatric, Total Body Less Head)",Phenotype,"Bone Mineral Density (Paediatric, Total Body Less Head)"
17933,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model),Phenotype,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model)
17936,Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Episode Treated With Electroconvulsive Therapy
17939,Brain Region Volumes,Phenotype,Brain Region Volumes
17944,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction)
17947,Self-Reported Math Ability (Mtag),Phenotype,Self-Reported Math Ability (Mtag)
17950,Fibrinogen,Phenotype,Fibrinogen
17952,Rbc Levels Of Udp-N-Acetyl-D-Glucosamine,Phenotype,Rbc Levels Of Udp-N-Acetyl-D-Glucosamine
17955,Edge-Level Brain Connectivity (Multivariate Analysis),Phenotype,Edge-Level Brain Connectivity (Multivariate Analysis)
17960,Noncognitive Aspects Of Educational Attainment,Phenotype,Noncognitive Aspects Of Educational Attainment
17962,Age At Menarche,Phenotype,Age At Menarche
17966,Restless Legs Syndrome,Phenotype,Restless Legs Syndrome
17971,Cerebrospinal Fluid Strem-2 Levels,Phenotype,Cerebrospinal Fluid Strem-2 Levels
17974,Coronary Artery Disease In Hypertension,Phenotype,Coronary Artery Disease In Hypertension
17977,Triglycerides To Total Lipids Ratio In Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Vldl
17981,Chitinase-3-Like Protein 2 Levels (Chi3L2.9383.24.3),Phenotype,Chitinase-3-Like Protein 2 Levels (Chi3L2.9383.24.3)
17982,Male-Pattern Baldness,Phenotype,Male-Pattern Baldness
17984,Eyebrow Thickness,Phenotype,Eyebrow Thickness
17986,Brevibacillus B Abundance In Stool,Phenotype,Brevibacillus B Abundance In Stool
17991,Monohexosylceramide (D16:1/22:0) Levels,Phenotype,Monohexosylceramide (D16:1/22:0) Levels
17997,Glutamine--Fructose-6-Phosphate Aminotransferase [Isomerizing] 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23669_20),Phenotype,Glutamine--Fructose-6-Phosphate Aminotransferase [Isomerizing] 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23669_20)
18001,Free Cholesterol Levels In Very Large Hdl,Phenotype,Free Cholesterol Levels In Very Large Hdl
18002,Orbital Telorism,Phenotype,Orbital Telorism
18004,Type 2 Diabetes (Adjusted For Bmi),Phenotype,Type 2 Diabetes (Adjusted For Bmi)
18009,Concentration Of Very Large Hdl Particles,Phenotype,Concentration Of Very Large Hdl Particles
18014,Eosinophil Percentage Of White Cells,Phenotype,Eosinophil Percentage Of White Cells
18018,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden),Phenotype,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden)
18024,Experiencing Mood Swings,Phenotype,Experiencing Mood Swings
18027,Concentration Of Large Hdl Particles,Phenotype,Concentration Of Large Hdl Particles
18029,Endosulfan Levels,Phenotype,Endosulfan Levels
18031,Attention Deficit Hyperactivity Disorder (Combined Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Combined Symptoms)
18033,Biliary Atresia,Phenotype,Biliary Atresia
18037,Primary Open Angle Glaucoma (Multi-Trait Analysis),Phenotype,Primary Open Angle Glaucoma (Multi-Trait Analysis)
18039,Toenail Selenium Levels,Phenotype,Toenail Selenium Levels
18042,Urinary Albumin Excretion Rate In Type 1 Diabetes,Phenotype,Urinary Albumin Excretion Rate In Type 1 Diabetes
18044,Otu97_119 (Desulfovibrio) Prevalence,Phenotype,Otu97_119 (Desulfovibrio) Prevalence
18046,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive),Phenotype,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive)
18051,Ebbinghaus Illusion (Overestimation),Phenotype,Ebbinghaus Illusion (Overestimation)
18054,Phospholipid Levels In Vldl,Phenotype,Phospholipid Levels In Vldl
18057,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test)
18060,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers
18063,Cholesterol Levels In Very Large Vldl,Phenotype,Cholesterol Levels In Very Large Vldl
18064,Triglyceride Levels In Hiv Infection,Phenotype,Triglyceride Levels In Hiv Infection
18066,Ulna And Radius Bone Mineral Density,Phenotype,Ulna And Radius Bone Mineral Density
18068,Serum Albumin Levels,Phenotype,Serum Albumin Levels
18070,Neutrophil Gelatinase-Associated Lipocalin Levels,Phenotype,Neutrophil Gelatinase-Associated Lipocalin Levels
18072,Diacylglycerol(34:2)_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol(34:2)_[M+H-H2O]1+ Levels
18074,Family History Of Alzheimer'S Disease,Phenotype,Family History Of Alzheimer'S Disease
18077,Immature Platelet Count,Phenotype,Immature Platelet Count
18079,Menarche (Age At Onset),Phenotype,Menarche (Age At Onset)
18083,Clostridium Difficile Infection In Multiple Myeloma,Phenotype,Clostridium Difficile Infection In Multiple Myeloma
18088,Major Depressive Disorder Or Stroke (Pleiotropy),Phenotype,Major Depressive Disorder Or Stroke (Pleiotropy)
18091,Common Executive Function,Phenotype,Common Executive Function
18095,Environmental Pollutants Exposure (Rfd High),Phenotype,Environmental Pollutants Exposure (Rfd High)
18099,"Sphingomyelin (D18:0/18:0, D19:0/17:0) Levels In Elite Athletes",Phenotype,"Sphingomyelin (D18:0/18:0, D19:0/17:0) Levels In Elite Athletes"
18102,Cholesterol Levels In Small Vldl,Phenotype,Cholesterol Levels In Small Vldl
18104,Gastric Atrophy,Phenotype,Gastric Atrophy
18109,Bronchopulmonary Dysplasia,Phenotype,Bronchopulmonary Dysplasia
18113,Granulocyte Percentage Of Myeloid White Cells,Phenotype,Granulocyte Percentage Of Myeloid White Cells
18115,Vaginal Microbiome Relative Abundance (S_Finegoldia Magna),Phenotype,Vaginal Microbiome Relative Abundance (S_Finegoldia Magna)
18117,Birth Weight,Phenotype,Birth Weight
18120,Coronary Artery Disease In Type 1 Diabetes,Phenotype,Coronary Artery Disease In Type 1 Diabetes
18122,General Factor Of Neuroticism,Phenotype,General Factor Of Neuroticism
18124,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
18126,Sleep (1-Day Periodicity),Phenotype,Sleep (1-Day Periodicity)
18128,Post-Traumatic Stress Disorder (Asjusted For Relatedness),Phenotype,Post-Traumatic Stress Disorder (Asjusted For Relatedness)
18132,Phosphatidylcholine Acyl-Alkyl C40:5 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C40:5 Levels
18135,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals
18140,Ca13/Grap2 Protein Level Ratio,Phenotype,Ca13/Grap2 Protein Level Ratio
18143,Age When Finished Full-Time Education (Weighted Gwa),Phenotype,Age When Finished Full-Time Education (Weighted Gwa)
18145,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect),Phenotype,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect)
18147,Albumin Levels,Phenotype,Albumin Levels
18149,High-Sensitivity Cardiac Troponin T Levels,Phenotype,High-Sensitivity Cardiac Troponin T Levels
18152,Postmenopausal Breast Cancer,Phenotype,Postmenopausal Breast Cancer
18154,Coro1A/Tbc1D5 Protein Level Ratio,Phenotype,Coro1A/Tbc1D5 Protein Level Ratio
18159,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I)
18161,Intelligence,Phenotype,Intelligence
18163,Leisure Screen Time,Phenotype,Leisure Screen Time
18167,Left Ventricular Internal Dimension In Systole,Phenotype,Left Ventricular Internal Dimension In Systole
18170,Triacylglycerol(53:3)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(53:3)_[M+Nh4]1+ Levels
18173,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447),Phenotype,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447)
18174,Low-Density Lipoprotein Levels (Mtag),Phenotype,Low-Density Lipoprotein Levels (Mtag)
18176,Coronary Artery Calcification,Phenotype,Coronary Artery Calcification
18178,Concentration Of Medium Vldl Particles (Ukb Data Field 23502),Phenotype,Concentration Of Medium Vldl Particles (Ukb Data Field 23502)
18185,Prostate Cancer (Snp X Snp Interaction),Phenotype,Prostate Cancer (Snp X Snp Interaction)
18188,Total Lipids In Large Hdl (Ukb Data Field 23559),Phenotype,Total Lipids In Large Hdl (Ukb Data Field 23559)
18191,Neutrophil Percentage Of White Cells,Phenotype,Neutrophil Percentage Of White Cells
18193,Valylglycine Levels (Advanced Age),Phenotype,Valylglycine Levels (Advanced Age)
18196,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy)
18200,Memory Decline In Normal Cognition,Phenotype,Memory Decline In Normal Cognition
18202,Total Triglycerides Levels (Ukb Data Field 23407),Phenotype,Total Triglycerides Levels (Ukb Data Field 23407)
18204,Cholesterol Levels In Idl,Phenotype,Cholesterol Levels In Idl
18206,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile),Phenotype,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile)
18208,1-Oleoyl-Gpg (18:1) Levels In Elite Athletes,Phenotype,1-Oleoyl-Gpg (18:1) Levels In Elite Athletes
18210,Angiopoietin-1 Levels,Phenotype,Angiopoietin-1 Levels
18212,Serum Creatinine Levels,Phenotype,Serum Creatinine Levels
18217,Blood Pressure Traits (Multi-Trait Analysis),Phenotype,Blood Pressure Traits (Multi-Trait Analysis)
18219,Ability To Confide In Someone,Phenotype,Ability To Confide In Someone
18221,Systemic Lupus Erythematosus (Mtag),Phenotype,Systemic Lupus Erythematosus (Mtag)
18223,Egf/Manf Protein Level Ratio,Phenotype,Egf/Manf Protein Level Ratio
18225,Cholesteryl Ester Levels In Ldl,Phenotype,Cholesteryl Ester Levels In Ldl
18230,Medial Orbital Frontal Cortex Volume,Phenotype,Medial Orbital Frontal Cortex Volume
18232,Ceramide (D40:1) Levels,Phenotype,Ceramide (D40:1) Levels
18236,Body Size (Confirmatory Factor Analysis Factor 21),Phenotype,Body Size (Confirmatory Factor Analysis Factor 21)
18240,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit),Phenotype,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit)
18242,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction
18244,Glycoprotein Acetylation,Phenotype,Glycoprotein Acetylation
18246,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose-I),Phenotype,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose-I)
18248,Baseline Memory,Phenotype,Baseline Memory
18251,Cd209 Antigen Levels,Phenotype,Cd209 Antigen Levels
18253,Cardiovascular Disease In Type 2 Diabetes,Phenotype,Cardiovascular Disease In Type 2 Diabetes
18256,Tonsillectomy,Phenotype,Tonsillectomy
18262,Ipcef1/Txlna Protein Level Ratio,Phenotype,Ipcef1/Txlna Protein Level Ratio
18265,Arachidonate 15-Lipoxygenase B Levels (Alox15B.12422.143.3),Phenotype,Arachidonate 15-Lipoxygenase B Levels (Alox15B.12422.143.3)
18271,Concentration Of Idl Particles,Phenotype,Concentration Of Idl Particles
18273,Asthma (Adult Onset),Phenotype,Asthma (Adult Onset)
18275,Phospholipid Levels In Small Ldl,Phenotype,Phospholipid Levels In Small Ldl
18278,Protein Biomarker,Phenotype,Protein Biomarker
18280,Ldl Cholesterol Levels,Phenotype,Ldl Cholesterol Levels
18287,Programmed Cell Death 1 Ligand 2 Levels,Phenotype,Programmed Cell Death 1 Ligand 2 Levels
18289,Vwf And Fviii Levels,Phenotype,Vwf And Fviii Levels
18294,Cholesterol Esters In Medium Vldl,Phenotype,Cholesterol Esters In Medium Vldl
18296,Colorectal Cancer,Phenotype,Colorectal Cancer
18298,Verbal-Numerical Reasoning,Phenotype,Verbal-Numerical Reasoning
18300,Neuronal Pentraxin-2 Levels,Phenotype,Neuronal Pentraxin-2 Levels
18303,Cerebral Aneurysm,Phenotype,Cerebral Aneurysm
18310,Total Cholesterol Levels (Ukb Data Field 23400),Phenotype,Total Cholesterol Levels (Ukb Data Field 23400)
18313,Total Lipids In Small Vldl,Phenotype,Total Lipids In Small Vldl
18316,C3A Anaphylatoxin Levels,Phenotype,C3A Anaphylatoxin Levels
18318,Proteasome Activator Complex Subunit 1 Levels,Phenotype,Proteasome Activator Complex Subunit 1 Levels
18320,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483),Phenotype,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483)
18322,Human Milk Oligosaccharide Concentration (Disialyllacto-N-Hexaose),Phenotype,Human Milk Oligosaccharide Concentration (Disialyllacto-N-Hexaose)
18325,Arthritis (Juvenile Idiopathic),Phenotype,Arthritis (Juvenile Idiopathic)
18327,Glycosphingolipids (D42:2) Levels,Phenotype,Glycosphingolipids (D42:2) Levels
18331,Bipolar I Disorder,Phenotype,Bipolar I Disorder
18333,Life Satisfaction,Phenotype,Life Satisfaction
18335,Relative Protein Intake,Phenotype,Relative Protein Intake
18337,Phospholipids In Idl (Ukb Data Field 23525),Phenotype,Phospholipids In Idl (Ukb Data Field 23525)
18339,Triacylglycerol 56:6 Levels,Phenotype,Triacylglycerol 56:6 Levels
18342,Baseline Memory In Normal Cognition,Phenotype,Baseline Memory In Normal Cognition
18344,Fasting Total Lipids In Large Vldl,Phenotype,Fasting Total Lipids In Large Vldl
18347,Alzheimer'S Disease Or Hdl Levels (Pleiotropy),Phenotype,Alzheimer'S Disease Or Hdl Levels (Pleiotropy)
18349,Crohn'S Disease Or Leprosy (Opposite Effect),Phenotype,Crohn'S Disease Or Leprosy (Opposite Effect)
18353,Serum Levels Of Protein Prss57,Phenotype,Serum Levels Of Protein Prss57
18355,Cervical Cancer (Mtag),Phenotype,Cervical Cancer (Mtag)
18358,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615),Phenotype,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615)
18360,Monocyte Percentage Of White Cells,Phenotype,Monocyte Percentage Of White Cells
18362,Post-Traumatic Stress Disorder Symptom Severity (Hyperarousal),Phenotype,Post-Traumatic Stress Disorder Symptom Severity (Hyperarousal)
18364,Triglyceride Levels In Idl,Phenotype,Triglyceride Levels In Idl
18368,Baseline Memory In Normal Cognition X Sex Interaction,Phenotype,Baseline Memory In Normal Cognition X Sex Interaction
18370,Triglycerides In Very Small Vldl (Ukb Data Field 23522),Phenotype,Triglycerides In Very Small Vldl (Ukb Data Field 23522)
18372,Mitochondrial Dna Copy Number (Adjusted),Phenotype,Mitochondrial Dna Copy Number (Adjusted)
18376,Memory Decline In Normal Cognition X Sex Interaction,Phenotype,Memory Decline In Normal Cognition X Sex Interaction
18378,Plasma Letrozole Concentrations In Letrozole Treated Hormone-Receptor-Positive Breast Cancer,Phenotype,Plasma Letrozole Concentrations In Letrozole Treated Hormone-Receptor-Positive Breast Cancer
18380,Carotid Intima Media Thickness (Maximum),Phenotype,Carotid Intima Media Thickness (Maximum)
18382,Adenylyltransferase And Sulfurtransferase Mocs3 Levels,Phenotype,Adenylyltransferase And Sulfurtransferase Mocs3 Levels
18384,Medium Chain Acylcarnitines Levels (Dominant Genetic Model),Phenotype,Medium Chain Acylcarnitines Levels (Dominant Genetic Model)
18389,Triglycerides In Large Ldl,Phenotype,Triglycerides In Large Ldl
18391,Serum Galactose-Deficient Iga1 Levels In Iga Nephropathy,Phenotype,Serum Galactose-Deficient Iga1 Levels In Iga Nephropathy
18395,Intake Of Total Sugars,Phenotype,Intake Of Total Sugars
18398,Average Diameter For Vldl Particles (Ukb Data Field 23431),Phenotype,Average Diameter For Vldl Particles (Ukb Data Field 23431)
18402,Myeloid-Derived Growth Factor Levels,Phenotype,Myeloid-Derived Growth Factor Levels
18404,Ldl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week),Phenotype,Ldl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week)
18407,1-Stearoyl-2-Arachidonoyl-Gpe (18:0/20:4) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Arachidonoyl-Gpe (18:0/20:4) Levels In Elite Athletes
18412,Daytime Nap,Phenotype,Daytime Nap
18415,S-6-Hydroxywarfarin Levels,Phenotype,S-6-Hydroxywarfarin Levels
18418,Positive Affect,Phenotype,Positive Affect
18420,Docosahexaenoic Acid Levels,Phenotype,Docosahexaenoic Acid Levels
18424,Vldl Cholesterol Levels,Phenotype,Vldl Cholesterol Levels
18425,Chronic Sputum Production,Phenotype,Chronic Sputum Production
18428,Apolipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Apolipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction
18431,Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Large Vldl
18434,Cardiac Mri Latent Space,Phenotype,Cardiac Mri Latent Space
18439,"Tyrosine-Protein Kinase Receptor Tie-1, Soluble Levels (Tie1.2844.53.2)",Phenotype,"Tyrosine-Protein Kinase Receptor Tie-1, Soluble Levels (Tie1.2844.53.2)"
18445,Migraine - Clinic-Based,Phenotype,Migraine - Clinic-Based
18447,Serum Total Cholesterol Levels,Phenotype,Serum Total Cholesterol Levels
18448,Neurogenic Locus Notch Homolog Protein 1 Levels (Notch1.5107.7.2),Phenotype,Neurogenic Locus Notch Homolog Protein 1 Levels (Notch1.5107.7.2)
18450,Whole Body Fat Mass (Ukb Data Field 23100),Phenotype,Whole Body Fat Mass (Ukb Data Field 23100)
18453,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio,Phenotype,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio
18457,Mesd/Serpinb1 Protein Level Ratio,Phenotype,Mesd/Serpinb1 Protein Level Ratio
18460,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation,Phenotype,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation
18466,Cholesterol In Very Large Hdl (Ukb Data Field 23554),Phenotype,Cholesterol In Very Large Hdl (Ukb Data Field 23554)
18469,Soluble Urokinase Plasminogen Activator Receptor Levels,Phenotype,Soluble Urokinase Plasminogen Activator Receptor Levels
18473,Cognitive Performance (Processing Speed),Phenotype,Cognitive Performance (Processing Speed)
18481,Anti-Thyroid Peroxidase (Tpoab) And Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis,Phenotype,Anti-Thyroid Peroxidase (Tpoab) And Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis
18483,"Gut Microbiota (Bacterial Taxa, Hurdle Binary Method)",Phenotype,"Gut Microbiota (Bacterial Taxa, Hurdle Binary Method)"
18486,Pediatric Autoimmune Diseases,Phenotype,Pediatric Autoimmune Diseases
18488,Glaucoma (Primary Angle Closure),Phenotype,Glaucoma (Primary Angle Closure)
18494,Medication Use (Hmg Coa Reductase Inhibitors),Phenotype,Medication Use (Hmg Coa Reductase Inhibitors)
18499,Cholesterol Esters In Medium Hdl,Phenotype,Cholesterol Esters In Medium Hdl
18501,Total Sitosterol,Phenotype,Total Sitosterol
18504,Total Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Small Vldl
18505,Heart Failure (Multivariate Analysis),Phenotype,Heart Failure (Multivariate Analysis)
18507,Mitochondrial Dna Copy Number (Raw),Phenotype,Mitochondrial Dna Copy Number (Raw)
18510,Periodontal Microbiota,Phenotype,Periodontal Microbiota
18512,Granulocyte Count,Phenotype,Granulocyte Count
18514,Iris Heterochromicity,Phenotype,Iris Heterochromicity
18517,Anxiety X Caesarean-Section Interaction,Phenotype,Anxiety X Caesarean-Section Interaction
18519,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms,Phenotype,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms
18521,Cerebrospinal Fluid (N(1) + N(8))-Acetylspermidine Levels,Phenotype,Cerebrospinal Fluid (N(1) + N(8))-Acetylspermidine Levels
18523,Severe Autoimmune Type 2 Diabetes,Phenotype,Severe Autoimmune Type 2 Diabetes
18526,Fasting Blood Insulin (Bmi Interaction),Phenotype,Fasting Blood Insulin (Bmi Interaction)
18528,Reticulocyte Production Index,Phenotype,Reticulocyte Production Index
18530,Headache,Phenotype,Headache
18532,Delta Of The Red Cell Haemoglobins,Phenotype,Delta Of The Red Cell Haemoglobins
18534,Cognitive Aspects Of Educational Attainment,Phenotype,Cognitive Aspects Of Educational Attainment
18536,Random Glucose Levels,Phenotype,Random Glucose Levels
18537,Polyunsaturated Fatty Acid Levels,Phenotype,Polyunsaturated Fatty Acid Levels
18540,Total Protein Levels X Insomnia Interaction,Phenotype,Total Protein Levels X Insomnia Interaction
18544,Acute Graft-Versus-Host Disease (Stage 3 To 4) (Recipient Effect),Phenotype,Acute Graft-Versus-Host Disease (Stage 3 To 4) (Recipient Effect)
18546,Response To Antipsychotic Treatment,Phenotype,Response To Antipsychotic Treatment
18548,Cholelithiasis,Phenotype,Cholelithiasis
18550,Glucocorticoid-Induced Osteonecrosis,Phenotype,Glucocorticoid-Induced Osteonecrosis
18554,Smoking Initiation (Mtag),Phenotype,Smoking Initiation (Mtag)
18559,Nonsyndromic Cleft Lip With Or Without Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Or Without Cleft Palate
18561,Acute Lymphoblastic Leukemia (Adolescents And Young Adults),Phenotype,Acute Lymphoblastic Leukemia (Adolescents And Young Adults)
18563,Optic Nerve Measurement (Disc Area),Phenotype,Optic Nerve Measurement (Disc Area)
18565,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia,Phenotype,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia
18568,4-Ethylphenylsulfate Levels,Phenotype,4-Ethylphenylsulfate Levels
18570,Weight,Phenotype,Weight
18573,Total Amyloid (Snp X Snp Interaction),Phenotype,Total Amyloid (Snp X Snp Interaction)
18578,Early Cardiac Repolarization,Phenotype,Early Cardiac Repolarization
18580,Blood Pressure,Phenotype,Blood Pressure
18582,Total Fatty Acid Levels,Phenotype,Total Fatty Acid Levels
18584,Serum Levels Of Protein Il15Ra,Phenotype,Serum Levels Of Protein Il15Ra
18586,Non-Lobar Intracerebral Hemorrhage (Mtag),Phenotype,Non-Lobar Intracerebral Hemorrhage (Mtag)
18591,Dkk1/Sdc4 Protein Level Ratio,Phenotype,Dkk1/Sdc4 Protein Level Ratio
18593,Airway Wall Thickness,Phenotype,Airway Wall Thickness
18605,Nonatopic Asthma,Phenotype,Nonatopic Asthma
18609,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week),Phenotype,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week)
18613,Environmental Pollutants Exposure (Expo Low),Phenotype,Environmental Pollutants Exposure (Expo Low)
18615,Metabolonic Lactone Sulfate (X-12063) Levels,Phenotype,Metabolonic Lactone Sulfate (X-12063) Levels
18619,Lysophosphatidylcholine (19:0) (A) [Sn1] [104_Sn1] Levels,Phenotype,Lysophosphatidylcholine (19:0) (A) [Sn1] [104_Sn1] Levels
18621,Hepcidin/Ferritin Ratio,Phenotype,Hepcidin/Ferritin Ratio
18623,Pizza Liking,Phenotype,Pizza Liking
18626,Acute Lymphoblastic Leukemia (Childhood),Phenotype,Acute Lymphoblastic Leukemia (Childhood)
18630,Neuritic Plaques (Snp X Snp Interaction),Phenotype,Neuritic Plaques (Snp X Snp Interaction)
18632,Cholesterol Levels In Large Hdl,Phenotype,Cholesterol Levels In Large Hdl
18634,Magnesium Levels,Phenotype,Magnesium Levels
18637,Rest Ukbbica Nodeamps25 0013,Phenotype,Rest Ukbbica Nodeamps25 0013
18639,5-Methylthioadenosine (Mta) Levels In Elite Athletes,Phenotype,5-Methylthioadenosine (Mta) Levels In Elite Athletes
18649,Total Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Large Hdl
18658,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144)
18659,Axin1/Srpk2 Protein Level Ratio,Phenotype,Axin1/Srpk2 Protein Level Ratio
18660,Granulysin Levels,Phenotype,Granulysin Levels
18663,1-Methylhistidine Levels In Elite Athletes,Phenotype,1-Methylhistidine Levels In Elite Athletes
18666,Phosphatidylcholine-O_42:6_[M+Oac]1-/Phosphatidylcholine-P_42:5_[M+Oac]1- Levels,Phenotype,Phosphatidylcholine-O_42:6_[M+Oac]1-/Phosphatidylcholine-P_42:5_[M+Oac]1- Levels
18667,Fatty Acid(20:4)_[M-H]1- Levels,Phenotype,Fatty Acid(20:4)_[M-H]1- Levels
18672,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- Levels
18677,Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+Nh4]1+ Levels
18679,X-21470 Levels,Phenotype,X-21470 Levels
18682,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels
18684,Diacylglycerol_38:4_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:4_[M+H-H2O]1+ Levels
18686,Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+Nh4]1+ Levels,Phenotype,Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+Nh4]1+ Levels
18688,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score)
18690,Glaucoma (Primary Open-Angle),Phenotype,Glaucoma (Primary Open-Angle)
18692,Colorectal Cancer Or Advanced Adenoma,Phenotype,Colorectal Cancer Or Advanced Adenoma
18695,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy
18697,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591),Phenotype,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591)
18699,Arachidonate (20:4N6) Levels (Elderly Offspring),Phenotype,Arachidonate (20:4N6) Levels (Elderly Offspring)
18702,Sphingomyelin(42:3)_[M+H]1+ Levels,Phenotype,Sphingomyelin(42:3)_[M+H]1+ Levels
18707,Phosphatidylcholine (14:0_20:4) Levels,Phenotype,Phosphatidylcholine (14:0_20:4) Levels
18709,Fatty Acid(22:4)_[M-H]1- Levels,Phenotype,Fatty Acid(22:4)_[M-H]1- Levels
18711,Phosphatidylcholine-2O_32:0_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-2O_32:0_[M+H]1+ Levels
18715,Phosphatidylcholine Diacyl C40:4 Levels,Phenotype,Phosphatidylcholine Diacyl C40:4 Levels
18724,Diacylglycerol (18:1_18:1) Levels,Phenotype,Diacylglycerol (18:1_18:1) Levels
18727,Phosphatidylethanolamine(34:2)_[M+H]1+ Levels,Phenotype,Phosphatidylethanolamine(34:2)_[M+H]1+ Levels
18737,Phospholipid Levels In Large Hdl,Phenotype,Phospholipid Levels In Large Hdl
18739,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Tender 28-Joint Count),Phenotype,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Tender 28-Joint Count)
18741,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis,Phenotype,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis
18743,Corpus Callosum Mid-Posterior Volume,Phenotype,Corpus Callosum Mid-Posterior Volume
18745,Cholesteryl Ester(20:4)_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester(20:4)_[M+Nh4]1+ Levels
18747,Metabolite Peak Levels (Qi7019),Phenotype,Metabolite Peak Levels (Qi7019)
18748,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase))
18751,Protein Fam134B Levels,Phenotype,Protein Fam134B Levels
18753,Eosinophil Percentage Of Granulocytes,Phenotype,Eosinophil Percentage Of Granulocytes
18756,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588),Phenotype,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588)
18760,Qrs Duration In Tripanosoma Cruzi Seropositivity,Phenotype,Qrs Duration In Tripanosoma Cruzi Seropositivity
18762,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpe (P-18:0/18:2) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpe (P-18:0/18:2) Levels
18765,Icd10 J30: Vasomotor And Allergic Rhinitis,Phenotype,Icd10 J30: Vasomotor And Allergic Rhinitis
18770,"Allergic Disease (Asthma, Hay Fever Or Eczema)",Phenotype,"Allergic Disease (Asthma, Hay Fever Or Eczema)"
18773,Phospholipids In Large Hdl (Ukb Data Field 23560),Phenotype,Phospholipids In Large Hdl (Ukb Data Field 23560)
18774,Erythrocyte Cadmium Concentration,Phenotype,Erythrocyte Cadmium Concentration
18776,Total Cholesterol To Total Lipids Ratio In Idl,Phenotype,Total Cholesterol To Total Lipids Ratio In Idl
18782,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
18784,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels
18787,Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- Levels
18789,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels
18791,"Non-Response To Survey Questionnaires: ""I Don'T Know"" Item",Phenotype,"Non-Response To Survey Questionnaires: ""I Don'T Know"" Item"
18793,Glutaminyl-Peptide Cyclotransferase Levels,Phenotype,Glutaminyl-Peptide Cyclotransferase Levels
18795,1-Meadoyl-Gpc (20:3N9) Levels,Phenotype,1-Meadoyl-Gpc (20:3N9) Levels
18801,Blood Glucose Levels,Phenotype,Blood Glucose Levels
18804,Serum Metabolite Levels (Cms),Phenotype,Serum Metabolite Levels (Cms)
18806,Cd3 On Naive Cd8+ T Cell,Phenotype,Cd3 On Naive Cd8+ T Cell
18809,Dyslexia,Phenotype,Dyslexia
18812,Lysophosphatidylcholine (20:2) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (20:2) [Sn2] Levels
18814,Hearing Problems,Phenotype,Hearing Problems
18816,Parental Extreme Longevity (95 Years And Older),Phenotype,Parental Extreme Longevity (95 Years And Older)
18818,Triglycerides To Total Lipids Ratio In Small Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Small Vldl
18821,Phosphatidylglycerol(36:0)_[M-H]1- Levels,Phenotype,Phosphatidylglycerol(36:0)_[M-H]1- Levels
18824,Itgb1Bp2/Mitd1 Protein Level Ratio,Phenotype,Itgb1Bp2/Mitd1 Protein Level Ratio
18826,Sterol Ester (27:1/17:1) Levels,Phenotype,Sterol Ester (27:1/17:1) Levels
18828,Cognitive Performance,Phenotype,Cognitive Performance
18833,1-Arachidonoyl-Gpa (20:4) Levels,Phenotype,1-Arachidonoyl-Gpa (20:4) Levels
18836,Fusiform Gyrus Volume,Phenotype,Fusiform Gyrus Volume
18845,Brugada Syndrome,Phenotype,Brugada Syndrome
18847,Uterine Fibroids,Phenotype,Uterine Fibroids
18849,Vitamin E Levels,Phenotype,Vitamin E Levels
18853,Phosphatidylcholine (18:0_22:5) (N6) Levels,Phenotype,Phosphatidylcholine (18:0_22:5) (N6) Levels
18855,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ Levels
18856,Phosphatidylcholine_44:5_[M+Oac]1- Levels,Phenotype,Phosphatidylcholine_44:5_[M+Oac]1- Levels
18858,Phosphatidylinositol (18:0_18:1) Levels,Phenotype,Phosphatidylinositol (18:0_18:1) Levels
18859,Switch-Associated Protein 70 Levels,Phenotype,Switch-Associated Protein 70 Levels
18862,Skin Phototype Score,Phenotype,Skin Phototype Score
18864,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure),Phenotype,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure)
18877,Progressive Supranuclear Palsy,Phenotype,Progressive Supranuclear Palsy
18879,Ccn2/Eno2 Protein Level Ratio,Phenotype,Ccn2/Eno2 Protein Level Ratio
18881,Metabolite Levels (Betaine),Phenotype,Metabolite Levels (Betaine)
18887,Omega-3 Fatty Acids Levels,Phenotype,Omega-3 Fatty Acids Levels
18890,Hbegf/Pdgfa Protein Level Ratio,Phenotype,Hbegf/Pdgfa Protein Level Ratio
18892,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
18894,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease
18898,Cd27 On Memory B Cell,Phenotype,Cd27 On Memory B Cell
18910,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate))
18913,Resting-State Electroencephalogram Vigilance,Phenotype,Resting-State Electroencephalogram Vigilance
18916,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio,Phenotype,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio
18919,Ratio Of Triglycerides To Phosphoglycerides,Phenotype,Ratio Of Triglycerides To Phosphoglycerides
18926,Ascending Thoracic Aortic Diameter,Phenotype,Ascending Thoracic Aortic Diameter
18928,Free Cholesterol In Large Hdl (Ukb Data Field 23563),Phenotype,Free Cholesterol In Large Hdl (Ukb Data Field 23563)
18930,Leukocyte Telomere Length,Phenotype,Leukocyte Telomere Length
18932,Deoxycarnitine Levels,Phenotype,Deoxycarnitine Levels
18935,Glioma Pathogenesis-Related Protein 1 Levels,Phenotype,Glioma Pathogenesis-Related Protein 1 Levels
18937,Cholesterol Esters In Large Hdl,Phenotype,Cholesterol Esters In Large Hdl
18939,Hip Circumference,Phenotype,Hip Circumference
18942,Low-Carbohydrate Diet (Lcd) Score,Phenotype,Low-Carbohydrate Diet (Lcd) Score
18954,Glomerular Filtration Rate,Phenotype,Glomerular Filtration Rate
18958,Cardiovascular Disease,Phenotype,Cardiovascular Disease
18964,Breast Cancer In Brca1 Mutation Carriers,Phenotype,Breast Cancer In Brca1 Mutation Carriers
18970,Cd300C/Clec14A Protein Level Ratio,Phenotype,Cd300C/Clec14A Protein Level Ratio
18977,Lysophosphatidylinositol (20:4) [Sn2] Levels,Phenotype,Lysophosphatidylinositol (20:4) [Sn2] Levels
18979,Glycerophosphoethanolamine Levels In Elite Athletes,Phenotype,Glycerophosphoethanolamine Levels In Elite Athletes
18982,Non-Albumin Protein Levels,Phenotype,Non-Albumin Protein Levels
18984,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy),Phenotype,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy)
18986,Alzheimer'S Disease,Phenotype,Alzheimer'S Disease
18989,Gamma-Glutamylphenylalanine Levels,Phenotype,Gamma-Glutamylphenylalanine Levels
18992,Aspartate Levels,Phenotype,Aspartate Levels
18994,Skull Bone Mineral Density,Phenotype,Skull Bone Mineral Density
18999,Celiac Disease,Phenotype,Celiac Disease
19002,Phenylalanine Levels (Ukb Data Field 23468),Phenotype,Phenylalanine Levels (Ukb Data Field 23468)
19004,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway))
19008,Free Cholesterol Levels,Phenotype,Free Cholesterol Levels
19011,Serum Levels Of Protein Scin,Phenotype,Serum Levels Of Protein Scin
19014,Headache Or Migraine,Phenotype,Headache Or Migraine
19017,Alzheimer'S Disease In Non-Apoe E4 Carriers,Phenotype,Alzheimer'S Disease In Non-Apoe E4 Carriers
19020,Adiponectin Levels,Phenotype,Adiponectin Levels
19022,Hippocampal Subfield Left Ca4 Volume (Body),Phenotype,Hippocampal Subfield Left Ca4 Volume (Body)
19034,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour)
19038,Icd10 J36: Peritonsillar Abscess,Phenotype,Icd10 J36: Peritonsillar Abscess
19042,Metabolite Levels (Taurocholenate Sulfate),Phenotype,Metabolite Levels (Taurocholenate Sulfate)
19044,Clec1B/Nsfl1C Protein Level Ratio,Phenotype,Clec1B/Nsfl1C Protein Level Ratio
19051,Glutamate Levels,Phenotype,Glutamate Levels
19056,Body Mass Index Or Osteoarthritis (Pleiotropy),Phenotype,Body Mass Index Or Osteoarthritis (Pleiotropy)
19059,Parkinson'S Disease (Age Of Onset),Phenotype,Parkinson'S Disease (Age Of Onset)
19065,Serum Uric Acid Levels,Phenotype,Serum Uric Acid Levels
19069,Verbal Learning (Visual Presentation),Phenotype,Verbal Learning (Visual Presentation)
19071,Ccr2 On Cd14- Cd16-,Phenotype,Ccr2 On Cd14- Cd16-
19073,Major Depressive Disorder (Broad),Phenotype,Major Depressive Disorder (Broad)
19075,Cd69/F11R Protein Level Ratio,Phenotype,Cd69/F11R Protein Level Ratio
19077,Glutamine Levels,Phenotype,Glutamine Levels
19082,Fibroblast Growth Factor 23 Levels,Phenotype,Fibroblast Growth Factor 23 Levels
19084,White Blood Cell Count (Monocyte),Phenotype,White Blood Cell Count (Monocyte)
19088,Plasma Amyloid Beta Peptide Concentrations (Abx-40),Phenotype,Plasma Amyloid Beta Peptide Concentrations (Abx-40)
19091,Switched Memory B Cell Absolute Count,Phenotype,Switched Memory B Cell Absolute Count
19098,Cognitive Function (Generalized Correlation Coefficient),Phenotype,Cognitive Function (Generalized Correlation Coefficient)
19103,Age-Related Macular Degeneration,Phenotype,Age-Related Macular Degeneration
19106,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii)
19108,Collagen Type Ii Levels,Phenotype,Collagen Type Ii Levels
19116,Visceral Adipose Tissue Adjusted For Bmi,Phenotype,Visceral Adipose Tissue Adjusted For Bmi
19119,Telomere Length (Principal Component 1),Phenotype,Telomere Length (Principal Component 1)
19121,Glomerular Load Of Uric Acid,Phenotype,Glomerular Load Of Uric Acid
19125,Low Hand Grip Strength (60 Years And Older) (Ewgsop),Phenotype,Low Hand Grip Strength (60 Years And Older) (Ewgsop)
19135,Craniofacial Microsomia,Phenotype,Craniofacial Microsomia
19137,Cognitive Function (Kinship Model),Phenotype,Cognitive Function (Kinship Model)
19139,Gamma-Cehc Levels In Elite Athletes,Phenotype,Gamma-Cehc Levels In Elite Athletes
19146,Hepatitis,Phenotype,Hepatitis
19148,Uterine Fibroids (Mtag),Phenotype,Uterine Fibroids (Mtag)
19150,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes,Phenotype,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes
19153,Guanine Nucleotide Exchange Factor Dbs Levels,Phenotype,Guanine Nucleotide Exchange Factor Dbs Levels
19156,Hypothyroidism,Phenotype,Hypothyroidism
19162,Covid-19 (Severe Vs Population) X Multiple Deprivation Index Interaction,Phenotype,Covid-19 (Severe Vs Population) X Multiple Deprivation Index Interaction
19165,Coagulation Factor Xa Levels,Phenotype,Coagulation Factor Xa Levels
19168,Ischemic Stroke (Large Artery Atherosclerosis),Phenotype,Ischemic Stroke (Large Artery Atherosclerosis)
19170,Preeclampsia Or Eclampsia,Phenotype,Preeclampsia Or Eclampsia
19173,Lung Function (Fev1/Fvc),Phenotype,Lung Function (Fev1/Fvc)
19177,Leucine Levels In Elite Athletes,Phenotype,Leucine Levels In Elite Athletes
19180,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae)
19185,Propionylcarnitine (C3) Levels,Phenotype,Propionylcarnitine (C3) Levels
19187,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder
19191,Vaginal Microbiome Metacyc Pathway (Pwy-7431|Aromatic Biogenic Amine Degradation (Bacteria)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7431|Aromatic Biogenic Amine Degradation (Bacteria))
19193,Intelligence (Mtag),Phenotype,Intelligence (Mtag)
19196,Dental Development,Phenotype,Dental Development
19199,Irritable Temperament,Phenotype,Irritable Temperament
19204,Verbal Short Term Memory (Paragraph Recall Test),Phenotype,Verbal Short Term Memory (Paragraph Recall Test)
19207,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639),Phenotype,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639)
19209,Hippocampal Volume In Mild Cognitive Impairment,Phenotype,Hippocampal Volume In Mild Cognitive Impairment
19211,Tuberculosis,Phenotype,Tuberculosis
19213,Protocadherin-9 Levels,Phenotype,Protocadherin-9 Levels
19220,Nrcam/Pcdh17 Protein Level Ratio,Phenotype,Nrcam/Pcdh17 Protein Level Ratio
19222,Platelet Count During  Second Trimester Of Pregnancy,Phenotype,Platelet Count During  Second Trimester Of Pregnancy
19224,Middle Temporal Gyrus Volume,Phenotype,Middle Temporal Gyrus Volume
19226,Suicide,Phenotype,Suicide
19229,Serum Nickel Levels,Phenotype,Serum Nickel Levels
19232,Placental Abruption,Phenotype,Placental Abruption
19235,Reaction Time (Standard Gwa),Phenotype,Reaction Time (Standard Gwa)
19239,Concentration Of Very Large Vldl Particles,Phenotype,Concentration Of Very Large Vldl Particles
19241,Systolic Blood Pressure (Mtag),Phenotype,Systolic Blood Pressure (Mtag)
19243,Tauroursodeoxycholate Levels In Elite Athletes,Phenotype,Tauroursodeoxycholate Levels In Elite Athletes
19250,Diabetes (Standard Gwa),Phenotype,Diabetes (Standard Gwa)
19252,Smoking Status (Ever Vs Never Smokers),Phenotype,Smoking Status (Ever Vs Never Smokers)
19254,B Cell Lymphocyte Profile Difference,Phenotype,B Cell Lymphocyte Profile Difference
19258,Platelet Reactivity In Response To Clopidogrel Treatment,Phenotype,Platelet Reactivity In Response To Clopidogrel Treatment
19261,Acute Post-Radiotherapy Pain In Breast Cancer,Phenotype,Acute Post-Radiotherapy Pain In Breast Cancer
19263,Serum Levels Of Protein Apln,Phenotype,Serum Levels Of Protein Apln
19265,Multisite Chronic Pain,Phenotype,Multisite Chronic Pain
19269,Thrombocytopenia In Coronary Artery Bypass Surgery,Phenotype,Thrombocytopenia In Coronary Artery Bypass Surgery
19271,Inflammatory Or Infectious Upper Respiratory Disease,Phenotype,Inflammatory Or Infectious Upper Respiratory Disease
19277,Caudate Activity During Reward,Phenotype,Caudate Activity During Reward
19281,"Schizophrenia, Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df)",Phenotype,"Schizophrenia, Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df)"
19289,Autism Spectrum Disorder,Phenotype,Autism Spectrum Disorder
19292,Hemoglobin A1C Levels,Phenotype,Hemoglobin A1C Levels
19296,Rate Of Ventricular Enlargement,Phenotype,Rate Of Ventricular Enlargement
19298,Chronic Obstructive Pulmonary Disease (Severe),Phenotype,Chronic Obstructive Pulmonary Disease (Severe)
19311,Posterior Thalamic Nuclei Volume,Phenotype,Posterior Thalamic Nuclei Volume
19315,Serum Levels Of Protein Ambn,Phenotype,Serum Levels Of Protein Ambn
19319,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin,Phenotype,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin
19323,Concentration Of Medium Ldl Particles,Phenotype,Concentration Of Medium Ldl Particles
19325,Sphingomyelin_39:1_[M+H]1+ Levels,Phenotype,Sphingomyelin_39:1_[M+H]1+ Levels
19327,Cancer,Phenotype,Cancer
19330,Morning Person,Phenotype,Morning Person
19334,Multiple Myeloma (Hyperdiploidy),Phenotype,Multiple Myeloma (Hyperdiploidy)
19336,Severe Influenza A (H1N1) Infection,Phenotype,Severe Influenza A (H1N1) Infection
19338,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure),Phenotype,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure)
19340,Plasma Tetradecadienedioate (C14:2-Dc)* Levels In Chronic Kidney Disease,Phenotype,Plasma Tetradecadienedioate (C14:2-Dc)* Levels In Chronic Kidney Disease
19346,Complement C1Q Tumor Necrosis Factor-Related Protein 1 Levels,Phenotype,Complement C1Q Tumor Necrosis Factor-Related Protein 1 Levels
19348,Hepatitis B,Phenotype,Hepatitis B
19350,Basophil Percentage Of White Cells,Phenotype,Basophil Percentage Of White Cells
19353,Visfatin Levels,Phenotype,Visfatin Levels
19356,Sphingomyelin_33:1_[M+H]1+ Levels,Phenotype,Sphingomyelin_33:1_[M+H]1+ Levels
19362,Cathepsin L1 Levels,Phenotype,Cathepsin L1 Levels
19364,Maleylacetoacetate Isomerase Levels,Phenotype,Maleylacetoacetate Isomerase Levels
19366,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes
19368,Alzheimer'S Disease Or Gastroesophageal Reflux Disease,Phenotype,Alzheimer'S Disease Or Gastroesophageal Reflux Disease
19371,Igg Glycosylation Patterns,Phenotype,Igg Glycosylation Patterns
19373,Diacylglycerol_42:7_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_42:7_[M+H-H2O]1+ Levels
19377,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I)
19380,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3),Phenotype,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3)
19381,Testasv_28 (Holdemanella) Prevalence,Phenotype,Testasv_28 (Holdemanella) Prevalence
19385,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction),Phenotype,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction)
19387,Familial Squamous Cell Lung Carcinoma,Phenotype,Familial Squamous Cell Lung Carcinoma
19390,Triglycerides In Small Ldl,Phenotype,Triglycerides In Small Ldl
19393,Bitter Alcoholic Beverage Consumption,Phenotype,Bitter Alcoholic Beverage Consumption
19399,X-21411 Levels,Phenotype,X-21411 Levels
19402,Iris Color (B* Coordinate),Phenotype,Iris Color (B* Coordinate)
19404,Serum Levels Of Protein Ptprn2,Phenotype,Serum Levels Of Protein Ptprn2
19406,Testasv_48 (Sutterella) Abundance,Phenotype,Testasv_48 (Sutterella) Abundance
19409,Seropositivity For Bacteroides Uniformis (Agilent_127067),Phenotype,Seropositivity For Bacteroides Uniformis (Agilent_127067)
19413,Tenofovir Clearance In Hiv Infection,Phenotype,Tenofovir Clearance In Hiv Infection
19418,N-Palmitoyl-Heptadecasphingosine (D17:1/16:0) Levels,Phenotype,N-Palmitoyl-Heptadecasphingosine (D17:1/16:0) Levels
19420,Sphingomyelin 24:0 Levels,Phenotype,Sphingomyelin 24:0 Levels
19422,Abdominal Fat Cell Number,Phenotype,Abdominal Fat Cell Number
19425,Clinical Ldl Cholesterol Levels,Phenotype,Clinical Ldl Cholesterol Levels
19431,Ectonucleoside Triphosphate Diphosphohydrolase 5 Levels,Phenotype,Ectonucleoside Triphosphate Diphosphohydrolase 5 Levels
19434,Triglyceride Levels X Loop Diuretics Use Interaction,Phenotype,Triglyceride Levels X Loop Diuretics Use Interaction
19439,Paired Immunoglobulin-Like Type 2 Receptor Alpha Levels (Pilra.8683.119.3),Phenotype,Paired Immunoglobulin-Like Type 2 Receptor Alpha Levels (Pilra.8683.119.3)
19444,Environmental Pollutants Exposure (Ac50 Low),Phenotype,Environmental Pollutants Exposure (Ac50 Low)
19448,Pallidum Volume,Phenotype,Pallidum Volume
19450,Problematic Alcohol Use,Phenotype,Problematic Alcohol Use
19456,Peanut Allergy,Phenotype,Peanut Allergy
19458,G_Parasutterella Prevalence,Phenotype,G_Parasutterella Prevalence
19462,Osm/Tgfa Protein Level Ratio,Phenotype,Osm/Tgfa Protein Level Ratio
19464,Vaginal Microbiome Relative Abundance (S_Lactobacillus Iners),Phenotype,Vaginal Microbiome Relative Abundance (S_Lactobacillus Iners)
19467,Aparc-Desikan Rh Area Cuneus,Phenotype,Aparc-Desikan Rh Area Cuneus
19468,Metabolite Peak Levels (Qi9774),Phenotype,Metabolite Peak Levels (Qi9774)
19475,Alpha-1-Antitrypsin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3580_25),Phenotype,Alpha-1-Antitrypsin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3580_25)
19479,Chronic Sinusitis,Phenotype,Chronic Sinusitis
19481,Cortical Surface Area (Visual Pc2),Phenotype,Cortical Surface Area (Visual Pc2)
19484,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa),Phenotype,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa)
19486,Systolic Blood Pressure (Standard Gwa),Phenotype,Systolic Blood Pressure (Standard Gwa)
19491,Diacylglycerol_38:6_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:6_[M+H-H2O]1+ Levels
19494,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder,Phenotype,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder
19502,2-Stearoyl-Gpe (18:0) Levels,Phenotype,2-Stearoyl-Gpe (18:0) Levels
19506,Dapp1/Manf Protein Level Ratio,Phenotype,Dapp1/Manf Protein Level Ratio
19510,Aging (Eyeageacceleration),Phenotype,Aging (Eyeageacceleration)
19512,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia,Phenotype,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia
19517,Chronic Obstructive Pulmonary Disease In Ever Smokers,Phenotype,Chronic Obstructive Pulmonary Disease In Ever Smokers
19521,Eye Color,Phenotype,Eye Color
19523,Regional Cortical Thickness (Insula),Phenotype,Regional Cortical Thickness (Insula)
19525,Brown Vs. Black Hair Color,Phenotype,Brown Vs. Black Hair Color
19530,Cholesterol To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Very Small Vldl
19535,Albumin Levels (Ukb Data Field 23479),Phenotype,Albumin Levels (Ukb Data Field 23479)
19538,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452),Phenotype,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452)
19541,Childhood Maltreatment,Phenotype,Childhood Maltreatment
19545,Dab2/Erbin Protein Level Ratio,Phenotype,Dab2/Erbin Protein Level Ratio
19551,Basophil Forward Scatter Distribution Width,Phenotype,Basophil Forward Scatter Distribution Width
19554,Receptor Tyrosine-Protein Kinase Erbb-3 Levels,Phenotype,Receptor Tyrosine-Protein Kinase Erbb-3 Levels
19561,Risk-Taking Behavior (Multivariate Analysis),Phenotype,Risk-Taking Behavior (Multivariate Analysis)
19563,Free Cholesterol In Large Vldl (Ukb Data Field 23500),Phenotype,Free Cholesterol In Large Vldl (Ukb Data Field 23500)
19566,Lung Cancer In Ever Smokers,Phenotype,Lung Cancer In Ever Smokers
19569,Lysophosphatidylethanolamine (17:0) [Sn2] Levels,Phenotype,Lysophosphatidylethanolamine (17:0) [Sn2] Levels
19573,Glomerular Filtration Rate (Creatinine),Phenotype,Glomerular Filtration Rate (Creatinine)
19577,Total Cholesterol In Hdl2,Phenotype,Total Cholesterol In Hdl2
19578,Thyroid Hormone Levels,Phenotype,Thyroid Hormone Levels
19581,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect),Phenotype,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect)
19586,Skin Color (Fitzpatrick Scale),Phenotype,Skin Color (Fitzpatrick Scale)
19588,Phosphatidylcholines Levels (Ukb Data Field 23437),Phenotype,Phosphatidylcholines Levels (Ukb Data Field 23437)
19590,Diffusing Capacity Of Carbon Monoxide,Phenotype,Diffusing Capacity Of Carbon Monoxide
19594,Total Cholesterol Levels In Very Large Hdl,Phenotype,Total Cholesterol Levels In Very Large Hdl
19597,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
19601,Matrix-Remodeling-Associated Protein 8 Levels,Phenotype,Matrix-Remodeling-Associated Protein 8 Levels
19604,Phosphatidylethanolamine(36:4)_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine(36:4)_[M-H]1- Levels
19606,Insulin-Like Growth Factor 1 Levels,Phenotype,Insulin-Like Growth Factor 1 Levels
19608,Monoclonal Gammopathy Of Undetermined Significance,Phenotype,Monoclonal Gammopathy Of Undetermined Significance
19610,Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+Nh4]1+ Levels
19614,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648),Phenotype,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648)
19616,Hip Minimal Joint Space Width,Phenotype,Hip Minimal Joint Space Width
19620,1-Palmitoyl-Gpe (16:0) Levels,Phenotype,1-Palmitoyl-Gpe (16:0) Levels
19624,Sphingomyelins Levels (Ukb Data Field 23438),Phenotype,Sphingomyelins Levels (Ukb Data Field 23438)
19626,Tourette Syndrome,Phenotype,Tourette Syndrome
19635,Aspartate Aminotransferase To Alanine Aminotransferase Ratio,Phenotype,Aspartate Aminotransferase To Alanine Aminotransferase Ratio
19637,Febrile Seizures (Mmr Vaccine-Related),Phenotype,Febrile Seizures (Mmr Vaccine-Related)
19639,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593),Phenotype,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593)
19641,High-Sensitivity Cardiac Troponin I Concentration,Phenotype,High-Sensitivity Cardiac Troponin I Concentration
19643,Ppp1R12A/Txndc5 Protein Level Ratio,Phenotype,Ppp1R12A/Txndc5 Protein Level Ratio
19645,Triglycerides To Total Lipids Ratio In Very Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Very Large Vldl
19647,Phosphatidylethanolamine(36:4)_[M+H]1+ Levels,Phenotype,Phosphatidylethanolamine(36:4)_[M+H]1+ Levels
19651,Urinary Albumin-To-Creatinine Ratio,Phenotype,Urinary Albumin-To-Creatinine Ratio
19653,Predicted Developmental Stuttering,Phenotype,Predicted Developmental Stuttering
19655,Free Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Vldl
19657,Age-Related Macular Degeneration (Snp X Mitochondrial A4917G Interaction),Phenotype,Age-Related Macular Degeneration (Snp X Mitochondrial A4917G Interaction)
19660,Fasting Total Cholesterol In Idl,Phenotype,Fasting Total Cholesterol In Idl
19661,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+Nh4]1+ Levels
19663,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
19665,Free Cholesterol Levels In Large Hdl,Phenotype,Free Cholesterol Levels In Large Hdl
19667,Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 Levels,Phenotype,Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 Levels
19669,Phosphatidylcholine Acyl-Alkyl C36:3 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C36:3 Levels
19672,Periventricular White Matter Hyperintensities,Phenotype,Periventricular White Matter Hyperintensities
19676,Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Large Hdl
19677,General Risk Tolerance (Mtag),Phenotype,General Risk Tolerance (Mtag)
19680,Phosphatidylethanolamine (18:0_20:4) Levels,Phenotype,Phosphatidylethanolamine (18:0_20:4) Levels
19682,Global Cognition (Mini Mental State Examination),Phenotype,Global Cognition (Mini Mental State Examination)
19684,Emphysema Distribution In Smoking,Phenotype,Emphysema Distribution In Smoking
19688,Urea Levels,Phenotype,Urea Levels
19691,Myeloid White Cell Count,Phenotype,Myeloid White Cell Count
19693,Glomerular Filtration Rate In Non Diabetics (Creatinine),Phenotype,Glomerular Filtration Rate In Non Diabetics (Creatinine)
19697,Liver Enzyme Levels (Gamma-Glutamyl Transferase),Phenotype,Liver Enzyme Levels (Gamma-Glutamyl Transferase)
19701,Schizophrenia X Sex Interaction,Phenotype,Schizophrenia X Sex Interaction
19703,Aparc-A2009S Lh Area S-Intrapariet+P-Trans,Phenotype,Aparc-A2009S Lh Area S-Intrapariet+P-Trans
19705,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy),Phenotype,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy)
19708,Axin1/Clip2 Protein Level Ratio,Phenotype,Axin1/Clip2 Protein Level Ratio
19716,Phospholipid Levels In Hdl,Phenotype,Phospholipid Levels In Hdl
19720,Western Dietary Pattern,Phenotype,Western Dietary Pattern
19724,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy)
19728,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy)
19730,Descending Aorta Minimum Area,Phenotype,Descending Aorta Minimum Area
19733,Free Cholesterol To Total Lipids Ratio In Very Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Very Large Vldl
19736,3-(4-Hydroxyphenyl)Lactate Levels,Phenotype,3-(4-Hydroxyphenyl)Lactate Levels
19739,Circulating Leptin Levels,Phenotype,Circulating Leptin Levels
19743,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi),Phenotype,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi)
19746,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels,Phenotype,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels
19749,Total Lipids In Large Vldl (Ukb Data Field 23496),Phenotype,Total Lipids In Large Vldl (Ukb Data Field 23496)
19751,Alpha-Hydroxyisovalerate Levels,Phenotype,Alpha-Hydroxyisovalerate Levels
19753,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction),Phenotype,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction)
19755,Snoring,Phenotype,Snoring
19757,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels
19759,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401),Phenotype,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401)
19761,Pelvic Organ Prolapse X Maximum Birth Weight Interaction,Phenotype,Pelvic Organ Prolapse X Maximum Birth Weight Interaction
19767,Caffeine Consumption From Tea,Phenotype,Caffeine Consumption From Tea
19769,Urine X-24339 Levels In Chronic Kidney Disease,Phenotype,Urine X-24339 Levels In Chronic Kidney Disease
19771,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels,Phenotype,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels
19781,Serum Levels Of Protein Ccl22,Phenotype,Serum Levels Of Protein Ccl22
19783,Early-Onset Schizophrenia,Phenotype,Early-Onset Schizophrenia
19786,Principal Component-Derived Dietary Pattern 43,Phenotype,Principal Component-Derived Dietary Pattern 43
19790,Iga Nephropathy,Phenotype,Iga Nephropathy
19792,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer,Phenotype,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer
19794,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647),Phenotype,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647)
19797,Mean Platelet Volume During The Postpartum Period,Phenotype,Mean Platelet Volume During The Postpartum Period
19800,Serum Levels Of Protein Pomc,Phenotype,Serum Levels Of Protein Pomc
19802,Interleukin-34 Levels,Phenotype,Interleukin-34 Levels
19807,Dipeptidase 2 Levels,Phenotype,Dipeptidase 2 Levels
19811,Abdominal Subcutaneous Adipose Tissue Volume,Phenotype,Abdominal Subcutaneous Adipose Tissue Volume
19813,Alcohol Consumption (Drinks Per Week),Phenotype,Alcohol Consumption (Drinks Per Week)
19820,Glaucoma,Phenotype,Glaucoma
19822,Cocaine Dependence,Phenotype,Cocaine Dependence
19828,Response To Placebo Treatment In Childhood Asthma (Fvc Change),Phenotype,Response To Placebo Treatment In Childhood Asthma (Fvc Change)
19831,Bitter Non-Alcoholic Beverage Consumption,Phenotype,Bitter Non-Alcoholic Beverage Consumption
19833,Attention Deficit Hyperactivity Disorder (Inattention Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Inattention Symptoms)
19836,Glycoprotein Acetyls Levels,Phenotype,Glycoprotein Acetyls Levels
19840,Phosphatidylethanolamine(40:2)_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine(40:2)_[M-H]1- Levels
19842,Node-Level Brain Connectivity (Multivariate Analysis),Phenotype,Node-Level Brain Connectivity (Multivariate Analysis)
19845,Axin1/Itgb1Bp2 Protein Level Ratio,Phenotype,Axin1/Itgb1Bp2 Protein Level Ratio
19848,Subjective Well-Being,Phenotype,Subjective Well-Being
19850,"Hair Colour (Natural, Before Greying): Red (Ukb Data Field 1747_2)",Phenotype,"Hair Colour (Natural, Before Greying): Red (Ukb Data Field 1747_2)"
19853,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521),Phenotype,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521)
19855,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df),Phenotype,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df)
19860,Total Lipids In Very Large Vldl,Phenotype,Total Lipids In Very Large Vldl
19865,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels
19870,Total Cholesterol Levels (Mtag),Phenotype,Total Cholesterol Levels (Mtag)
19872,Chronic Graft-Versus-Host Disease (Recipient Effect),Phenotype,Chronic Graft-Versus-Host Disease (Recipient Effect)
19875,Breast Dense Area,Phenotype,Breast Dense Area
19878,Cd19 On Unswitched Memory B Cell,Phenotype,Cd19 On Unswitched Memory B Cell
19880,F-Highly Palatable Foods Liking (Derived Food-Liking Factor),Phenotype,F-Highly Palatable Foods Liking (Derived Food-Liking Factor)
19882,Body Mass Index (Age>50),Phenotype,Body Mass Index (Age>50)
19888,Metabolite Levels (Cysteinylglycine Disulfide),Phenotype,Metabolite Levels (Cysteinylglycine Disulfide)
19890,Mannitol/Sorbitol Levels,Phenotype,Mannitol/Sorbitol Levels
19892,Phospholipids In Large Vldl (Ukb Data Field 23497),Phenotype,Phospholipids In Large Vldl (Ukb Data Field 23497)
19895,Red Blood Cell Traits,Phenotype,Red Blood Cell Traits
19899,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep))
19901,Cd64 On Cd14+ Cd16+ Monocyte,Phenotype,Cd64 On Cd14+ Cd16+ Monocyte
19910,Testicular Germ Cell Tumor,Phenotype,Testicular Germ Cell Tumor
19913,Body Fat Distribution (Arm Fat Ratio),Phenotype,Body Fat Distribution (Arm Fat Ratio)
19917,Testosterone Levels,Phenotype,Testosterone Levels
19920,T-Cell Receptor Clonality In Colorectal Cancer,Phenotype,T-Cell Receptor Clonality In Colorectal Cancer
19922,C-Type Lectin Domain Family 2 Member D Levels (Clec2D.7054.87.3),Phenotype,C-Type Lectin Domain Family 2 Member D Levels (Clec2D.7054.87.3)
19923,Myopia (Pathological),Phenotype,Myopia (Pathological)
19926,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area),Phenotype,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area)
19928,Aurora Kinase B Levels (Aurkb.3346.72.2),Phenotype,Aurora Kinase B Levels (Aurkb.3346.72.2)
19930,25-Hydroxyvitamin D Levels (Skin Colour Stratified),Phenotype,25-Hydroxyvitamin D Levels (Skin Colour Stratified)
19932,Reaction Time,Phenotype,Reaction Time
19937,Systemic Lupus Erythematosus And Systemic Sclerosis,Phenotype,Systemic Lupus Erythematosus And Systemic Sclerosis
19942,Globulin Levels,Phenotype,Globulin Levels
19947,Mgmt Methylation In Smokers,Phenotype,Mgmt Methylation In Smokers
19949,Non-Glioblastoma Glioma,Phenotype,Non-Glioblastoma Glioma
19954,T1 Freesurfer Pial Rh Supramarginal Area,Phenotype,T1 Freesurfer Pial Rh Supramarginal Area
19957,Unilateral Cleft Lip And Palate,Phenotype,Unilateral Cleft Lip And Palate
19959,Colonoscopy-Negative Controls Vs Population Controls,Phenotype,Colonoscopy-Negative Controls Vs Population Controls
19961,Alzheimer'S Disease (Late Onset),Phenotype,Alzheimer'S Disease (Late Onset)
19963,Free Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Hdl
19966,Serum Levels Of Protein Stx8,Phenotype,Serum Levels Of Protein Stx8
19968,Col1A1/Omd Protein Level Ratio,Phenotype,Col1A1/Omd Protein Level Ratio
19969,Nicotine Dependence And Major Depression (Severity Of Comorbidity),Phenotype,Nicotine Dependence And Major Depression (Severity Of Comorbidity)
19972,Neurofibrillary Tangles,Phenotype,Neurofibrillary Tangles
19976,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602),Phenotype,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602)
19978,Ahsp/Blvrb Protein Level Ratio,Phenotype,Ahsp/Blvrb Protein Level Ratio
19982,Feeling Worry,Phenotype,Feeling Worry
19985,Uterine Fibroids And Heavy Menstrual Bleeding,Phenotype,Uterine Fibroids And Heavy Menstrual Bleeding
19987,Alcohol Consumption X Playing Computer Games Interaction,Phenotype,Alcohol Consumption X Playing Computer Games Interaction
19989,Blood Protein Levels In Cardiovascular Risk,Phenotype,Blood Protein Levels In Cardiovascular Risk
19991,Serum Vanadium Levels,Phenotype,Serum Vanadium Levels
19995,Idp Dmri Tbss L1 Uncinate Fasciculus L,Phenotype,Idp Dmri Tbss L1 Uncinate Fasciculus L
20001,Igd On Igd+ Cd24- B Cell,Phenotype,Igd On Igd+ Cd24- B Cell
20003,Hmbs/Pklr Protein Level Ratio,Phenotype,Hmbs/Pklr Protein Level Ratio
20005,Red Vs. Brown/Black Hair Color,Phenotype,Red Vs. Brown/Black Hair Color
20007,Phospholipids In Very Small Vldl (Ukb Data Field 23518),Phenotype,Phospholipids In Very Small Vldl (Ukb Data Field 23518)
20010,Serum Levels Of Protein St14,Phenotype,Serum Levels Of Protein St14
20013,Platelet Forward Scatter Distribution Width,Phenotype,Platelet Forward Scatter Distribution Width
20017,Regional Cortical Thickness (Paracentral),Phenotype,Regional Cortical Thickness (Paracentral)
20020,Total Phospholipid Levels In Lipoprotein Particles,Phenotype,Total Phospholipid Levels In Lipoprotein Particles
20021,Matrix Metalloproteinase-9 Levels,Phenotype,Matrix Metalloproteinase-9 Levels
20023,Severe Malaria,Phenotype,Severe Malaria
20026,Testasv_20 (Phascolarctobacterium) Prevalence,Phenotype,Testasv_20 (Phascolarctobacterium) Prevalence
20030,Tb-Lm Or Tblh-Bmd (Pleiotropy),Phenotype,Tb-Lm Or Tblh-Bmd (Pleiotropy)
20036,Serum Levels Of Protein Gp1Ba,Phenotype,Serum Levels Of Protein Gp1Ba
20038,Pyridoxate Levels In Elite Athletes,Phenotype,Pyridoxate Levels In Elite Athletes
20049,Gestational Length In Nulliparas,Phenotype,Gestational Length In Nulliparas
20052,Regional Cortical Thickness (Parstriangularis),Phenotype,Regional Cortical Thickness (Parstriangularis)
20057,C-C Motif Chemokine 8 Levels,Phenotype,C-C Motif Chemokine 8 Levels
20060,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae)
20063,Anxiety,Phenotype,Anxiety
20065,Valine Levels,Phenotype,Valine Levels
20068,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603),Phenotype,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603)
20071,Serum Levels Of Protein Ercc4,Phenotype,Serum Levels Of Protein Ercc4
20075,Ovarian Cancer,Phenotype,Ovarian Cancer
20078,Sulfasalazine-Induced Agranulocytosis,Phenotype,Sulfasalazine-Induced Agranulocytosis
20080,Mosaic Loss Of Chromosome X,Phenotype,Mosaic Loss Of Chromosome X
20081,Myopia (Age Of Diagnosis),Phenotype,Myopia (Age Of Diagnosis)
20084,Dna Methylation Phenoage Acceleration,Phenotype,Dna Methylation Phenoage Acceleration
20086,Triglycerides To Total Lipids Ratio In Idl,Phenotype,Triglycerides To Total Lipids Ratio In Idl
20088,Serum Levels Of Protein Azgp1,Phenotype,Serum Levels Of Protein Azgp1
20089,Serum Levels Of Protein Ifna2,Phenotype,Serum Levels Of Protein Ifna2
20090,Serum Levels Of Protein Uts2,Phenotype,Serum Levels Of Protein Uts2
20100,Retinal Vascular Fractal Dimension,Phenotype,Retinal Vascular Fractal Dimension
20112,Pr Interval In Tripanosoma Cruzi Seropositivity,Phenotype,Pr Interval In Tripanosoma Cruzi Seropositivity
20117,Asthma-Chronic Obstructive  Pulmonary Disease Overlap Syndrome,Phenotype,Asthma-Chronic Obstructive  Pulmonary Disease Overlap Syndrome
20120,Decaffeinated Coffee Consumption And/Or Insomnia,Phenotype,Decaffeinated Coffee Consumption And/Or Insomnia
20122,Depressive Symptoms X Stressful Life Events Interaction (2Df Test),Phenotype,Depressive Symptoms X Stressful Life Events Interaction (2Df Test)
20125,Subjective Well-Being (Mtag),Phenotype,Subjective Well-Being (Mtag)
20127,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632),Phenotype,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632)
20131,Calsequestrin-2 Levels,Phenotype,Calsequestrin-2 Levels
20135,Clostridioides Difficle Infection,Phenotype,Clostridioides Difficle Infection
20137,Rate Of Cognitive Decline In Alzheimer'S Disease,Phenotype,Rate Of Cognitive Decline In Alzheimer'S Disease
20141,Height (Weighted Gwa),Phenotype,Height (Weighted Gwa)
20145,Diabetic Retinopathy,Phenotype,Diabetic Retinopathy
20149,Waist Circumference,Phenotype,Waist Circumference
20155,Leg Fat Mass And Leg Lean Mass (Pleiotropy),Phenotype,Leg Fat Mass And Leg Lean Mass (Pleiotropy)
20157,Otu99_558 (Bacteroidales) Prevalence,Phenotype,Otu99_558 (Bacteroidales) Prevalence
20160,Sucrose Liking,Phenotype,Sucrose Liking
20162,Sitting Height Ratio,Phenotype,Sitting Height Ratio
20164,Phospholipids In Large Hdl,Phenotype,Phospholipids In Large Hdl
20165,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620),Phenotype,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620)
20166,Response To Exercise (Triglyceride Level Interaction),Phenotype,Response To Exercise (Triglyceride Level Interaction)
20171,Linoleic Acid Levels,Phenotype,Linoleic Acid Levels
20174,Ddt Metabolite (Ddt O-P') Levels,Phenotype,Ddt Metabolite (Ddt O-P') Levels
20176,Hydantoin-5-Propionic Acid Levels,Phenotype,Hydantoin-5-Propionic Acid Levels
20178,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure),Phenotype,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure)
20180,Thyroid Peroxidase Antibody Levels In Pregnancy,Phenotype,Thyroid Peroxidase Antibody Levels In Pregnancy
20182,Non-Small Cell Lung Cancer,Phenotype,Non-Small Cell Lung Cancer
20187,Cognitive Performance (Global Cognitive Function) (Longitudinal),Phenotype,Cognitive Performance (Global Cognitive Function) (Longitudinal)
20190,Baseline Memory X Sex Interaction,Phenotype,Baseline Memory X Sex Interaction
20193,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test),Phenotype,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test)
20196,Large Hdl Particle Concentration,Phenotype,Large Hdl Particle Concentration
20202,Acne Vulgaris,Phenotype,Acne Vulgaris
20204,Depression Severity  X Hours Spent Watching Television Interaction,Phenotype,Depression Severity  X Hours Spent Watching Television Interaction
20206,Parental Longevity (Mother'S Age At Death),Phenotype,Parental Longevity (Mother'S Age At Death)
20210,Cholesteryl Ester Levels In Small Hdl,Phenotype,Cholesteryl Ester Levels In Small Hdl
20215,Taurolithocholate 3-Sulfate Levels In Elite Athletes,Phenotype,Taurolithocholate 3-Sulfate Levels In Elite Athletes
20217,Metabolic Biomarkers (Multivariate Analysis),Phenotype,Metabolic Biomarkers (Multivariate Analysis)
20219,Morningness,Phenotype,Morningness
20221,3-Hydroxypropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxypropylmercapturic Acid Levels In Smokers
20228,Adverse Response To Drug,Phenotype,Adverse Response To Drug
20230,Rfmri Connectivity (Ica100 Edge 912),Phenotype,Rfmri Connectivity (Ica100 Edge 912)
20232,Gamma-Glutamyltryptophan Levels In Elite Athletes,Phenotype,Gamma-Glutamyltryptophan Levels In Elite Athletes
20235,Cognitive Function,Phenotype,Cognitive Function
20243,Asthma-Copd Overlap Syndrome,Phenotype,Asthma-Copd Overlap Syndrome
20248,Cognitive Function (Delayed Memory),Phenotype,Cognitive Function (Delayed Memory)
20251,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis,Phenotype,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis
20253,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels,Phenotype,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels
20256,Total Cholesterol Levels In Large Hdl,Phenotype,Total Cholesterol Levels In Large Hdl
20258,Depressed Affect,Phenotype,Depressed Affect
20260,Rostral Anterior Cingulate Cortex Volume,Phenotype,Rostral Anterior Cingulate Cortex Volume
20263,Hippocampal Volume,Phenotype,Hippocampal Volume
20273,Scarlet Fever,Phenotype,Scarlet Fever
20278,E3 Ubiquitin-Protein Ligase Smurf1 Levels,Phenotype,E3 Ubiquitin-Protein Ligase Smurf1 Levels
20280,Fractional Excretion Of Metabolites In Chronic Kidney Disease,Phenotype,Fractional Excretion Of Metabolites In Chronic Kidney Disease
20282,Corneal Resistance Factor (Mtag),Phenotype,Corneal Resistance Factor (Mtag)
20287,Pork Consumption,Phenotype,Pork Consumption
20292,Human Milk Oligosaccharide Concentration (Fucodisialyllacto-N-Hexaose),Phenotype,Human Milk Oligosaccharide Concentration (Fucodisialyllacto-N-Hexaose)
20293,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease,Phenotype,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease
20295,"Sphingomyelin (D18:1/20:0, D16:1/22:0) Levels",Phenotype,"Sphingomyelin (D18:1/20:0, D16:1/22:0) Levels"
20300,Phospholipids To Total Lipids Ratio In Idl,Phenotype,Phospholipids To Total Lipids Ratio In Idl
20305,Postprandial Phospholipid Levels In Very Small Vldl,Phenotype,Postprandial Phospholipid Levels In Very Small Vldl
20309,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl
20312,Phospholipid Levels In Small Vldl,Phenotype,Phospholipid Levels In Small Vldl
20314,Body Mass Index X Age Interaction,Phenotype,Body Mass Index X Age Interaction
20315,Calcium-Binding Protein 7 Levels,Phenotype,Calcium-Binding Protein 7 Levels
20316,Vitamin D Levels,Phenotype,Vitamin D Levels
20318,"Plasma Glycosyl Ceramide (D18:1/20:0, D16:1/22:0)* Levels In Chronic Kidney Disease",Phenotype,"Plasma Glycosyl Ceramide (D18:1/20:0, D16:1/22:0)* Levels In Chronic Kidney Disease"
20323,Amyloid Beta Positivity In Normal Cognition,Phenotype,Amyloid Beta Positivity In Normal Cognition
20324,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
20328,Kallikrein-11 Levels,Phenotype,Kallikrein-11 Levels
20331,Macular Thickness,Phenotype,Macular Thickness
20333,Immature Fraction Of Reticulocytes,Phenotype,Immature Fraction Of Reticulocytes
20336,Smoking Intensity (Cotinine Levels/Cigarettes Per Day),Phenotype,Smoking Intensity (Cotinine Levels/Cigarettes Per Day)
20337,Total Concentration Of 19 Human Milk Oligosaccharides,Phenotype,Total Concentration Of 19 Human Milk Oligosaccharides
20341,14-3-3 Protein Zeta/Delta Levels (Ywhaz.5858.6.5),Phenotype,14-3-3 Protein Zeta/Delta Levels (Ywhaz.5858.6.5)
20343,Corneocyte Area,Phenotype,Corneocyte Area
20345,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541),Phenotype,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541)
20349,Hematological And Biochemical Traits,Phenotype,Hematological And Biochemical Traits
20351,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601),Phenotype,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601)
20354,Brain Imaging,Phenotype,Brain Imaging
20355,Ldl (Standard Gwa),Phenotype,Ldl (Standard Gwa)
20357,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
20359,Covid-19 (Severe Vs Population),Phenotype,Covid-19 (Severe Vs Population)
20363,Kallikrein-7 Levels,Phenotype,Kallikrein-7 Levels
20368,Microtubule-Associated Proteins 1A/1B Light Chain 3 Beta 2 Levels,Phenotype,Microtubule-Associated Proteins 1A/1B Light Chain 3 Beta 2 Levels
20376,Apolipoprotein E (Isoform E2) Levels,Phenotype,Apolipoprotein E (Isoform E2) Levels
20379,Cd209 Antigen (Analyte X22576.1) Levels,Phenotype,Cd209 Antigen (Analyte X22576.1) Levels
20381,Tyrosine-Protein Kinase Lck Levels (Lck.4560.34.2),Phenotype,Tyrosine-Protein Kinase Lck Levels (Lck.4560.34.2)
20392,Myeloid Cell Surface Antigen Cd33 Levels,Phenotype,Myeloid Cell Surface Antigen Cd33 Levels
20394,Serum Levels Of Protein Ywhaq,Phenotype,Serum Levels Of Protein Ywhaq
20397,Resistin Levels,Phenotype,Resistin Levels
20400,Total Bilirubin Levels,Phenotype,Total Bilirubin Levels
20402,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594),Phenotype,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594)
20403,Hepatic Lipid Content In Extreme Obesity,Phenotype,Hepatic Lipid Content In Extreme Obesity
20405,Oleoyl Leucine Levels,Phenotype,Oleoyl Leucine Levels
20408,Phosphatidylcholine (36:0) Levels,Phenotype,Phosphatidylcholine (36:0) Levels
20410,Triglyceride Levels In Vldl,Phenotype,Triglyceride Levels In Vldl
20413,Ldl Cholesterol Levels (Ukb Data Field 23405),Phenotype,Ldl Cholesterol Levels (Ukb Data Field 23405)
20417,Alzheimer'S Disease In Hypertension,Phenotype,Alzheimer'S Disease In Hypertension
20418,Phosphatidylinositol (16:0_20:3) (A) Levels,Phenotype,Phosphatidylinositol (16:0_20:3) (A) Levels
20420,X-16654 Levels,Phenotype,X-16654 Levels
20422,Total Lipids In Idl,Phenotype,Total Lipids In Idl
20427,Uric Acid Clearance,Phenotype,Uric Acid Clearance
20429,Cholesteryl Esters To Total Lipids Ratio In Small Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Ldl
20433,Triglyceride Levels In Large Vldl,Phenotype,Triglyceride Levels In Large Vldl
20436,Lithostathine-1-Alpha Levels,Phenotype,Lithostathine-1-Alpha Levels
20439,Bladder Cancer,Phenotype,Bladder Cancer
20441,Free Cholesterol Levels In Small Vldl,Phenotype,Free Cholesterol Levels In Small Vldl
20444,Lutropin Subunit Beta Levels,Phenotype,Lutropin Subunit Beta Levels
20451,Opioid Analgesic Dose Requirement In Cancer Pain Treatment,Phenotype,Opioid Analgesic Dose Requirement In Cancer Pain Treatment
20456,Duodenal Ulcer,Phenotype,Duodenal Ulcer
20460,Neuritic Plaque,Phenotype,Neuritic Plaque
20463,Ldlr/Pcsk9 Protein Level Ratio,Phenotype,Ldlr/Pcsk9 Protein Level Ratio
20466,Sulfate Levels,Phenotype,Sulfate Levels
20469,Uromodulin Level In Chronic Kidney Disease With Hypertension And No Diabetes (9451_20),Phenotype,Uromodulin Level In Chronic Kidney Disease With Hypertension And No Diabetes (9451_20)
20476,Fms-Related Tyrosine Kinase 3 Ligand Levels,Phenotype,Fms-Related Tyrosine Kinase 3 Ligand Levels
20479,Prostate-Specific Antigen Levels (Conditioned On Lead Snps),Phenotype,Prostate-Specific Antigen Levels (Conditioned On Lead Snps)
20481,Cerebral Amyloid Deposition (Pet Imaging),Phenotype,Cerebral Amyloid Deposition (Pet Imaging)
20483,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [2] Levels,Phenotype,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [2] Levels
20484,Ceramide (D18:2/20:0) Levels,Phenotype,Ceramide (D18:2/20:0) Levels
20486,Ceramide (D19:1/26:0) Levels,Phenotype,Ceramide (D19:1/26:0) Levels
20488,Fasting Total Cholesterol In Very Large Hdl,Phenotype,Fasting Total Cholesterol In Very Large Hdl
20491,Whole Brain Restricted Directional Diffusion (Multivariate Analysis),Phenotype,Whole Brain Restricted Directional Diffusion (Multivariate Analysis)
20493,Spontaneous Preterm Birth (Maternal Effect),Phenotype,Spontaneous Preterm Birth (Maternal Effect)
20495,Balding Type 1,Phenotype,Balding Type 1
20497,Fasting Very Large Hdl Particle Concentration,Phenotype,Fasting Very Large Hdl Particle Concentration
20499,Triglyceride Levels In Current Drinkers,Phenotype,Triglyceride Levels In Current Drinkers
20502,Total Lipids In Small Ldl (Ukb Data Field 23545),Phenotype,Total Lipids In Small Ldl (Ukb Data Field 23545)
20506,Waist-To-Hip Ratio Adjusted For Bmi (Age >50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age >50)
20512,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638),Phenotype,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638)
20514,Ceramide (D18:1/26:0) Levels,Phenotype,Ceramide (D18:1/26:0) Levels
20517,Sphingomyelin(41:2)_[M+H]1+ Levels,Phenotype,Sphingomyelin(41:2)_[M+H]1+ Levels
20521,Putamen Volume,Phenotype,Putamen Volume
20525,Blood Sugar Levels,Phenotype,Blood Sugar Levels
20527,Concentration Of Vldl Particles,Phenotype,Concentration Of Vldl Particles
20535,Ceramide (D20:1/24:1) Levels,Phenotype,Ceramide (D20:1/24:1) Levels
20538,Measles,Phenotype,Measles
20541,"Sphingomyelin (D18:0/20:0, D16:0/22:0) Levels In Elite Athletes",Phenotype,"Sphingomyelin (D18:0/20:0, D16:0/22:0) Levels In Elite Athletes"
20547,Ceramide(40:0)_[M-H]1- Levels,Phenotype,Ceramide(40:0)_[M-H]1- Levels
20549,Sphingomyelin(37:1)_[M-Ch3]1- Levels,Phenotype,Sphingomyelin(37:1)_[M-Ch3]1- Levels
20552,Information Processing Speed,Phenotype,Information Processing Speed
20554,Sphingomyelin(37:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(37:1)_[M+H]1+ Levels
20557,Fasting Insulin,Phenotype,Fasting Insulin
20561,Cobalt Levels,Phenotype,Cobalt Levels
20569,Phospholipid Levels In Small Hdl,Phenotype,Phospholipid Levels In Small Hdl
20574,Retinal Nerve Fibre Layer (Rnfl) Thickness,Phenotype,Retinal Nerve Fibre Layer (Rnfl) Thickness
20577,Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis,Phenotype,Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis
20579,Idp Dmri Tbss L2 Superior Cerebellar Peduncle L,Phenotype,Idp Dmri Tbss L2 Superior Cerebellar Peduncle L
20581,Sphingomyelin(39:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(39:1)_[M+H]1+ Levels
20583,Cpxm1/Hbegf Protein Level Ratio,Phenotype,Cpxm1/Hbegf Protein Level Ratio
20585,Subcortical Volume (Min-P),Phenotype,Subcortical Volume (Min-P)
20590,Cystatin-C Levels,Phenotype,Cystatin-C Levels
20593,Heptachlor Epoxide Levels,Phenotype,Heptachlor Epoxide Levels
20598,Matrilin-4 Levels,Phenotype,Matrilin-4 Levels
20602,Waist-To-Hip Ratio Adjusted For Bmi (Age <50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age <50)
20604,Age At First Birth,Phenotype,Age At First Birth
20606,Ribavirin-Induced Anemia In Chronic Hepatitis C,Phenotype,Ribavirin-Induced Anemia In Chronic Hepatitis C
20614,Erosive Tooth Wear (Severe Vs Non-Severe),Phenotype,Erosive Tooth Wear (Severe Vs Non-Severe)
20620,Sphingomyelin (D43:1) Levels,Phenotype,Sphingomyelin (D43:1) Levels
20624,"Placental Weight (Fetal Genotype, Adjusted For Sex And Gestational Age)",Phenotype,"Placental Weight (Fetal Genotype, Adjusted For Sex And Gestational Age)"
20628,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate,Phenotype,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate
20634,Vaginal Microbiome Presence (C_Actinobacteria),Phenotype,Vaginal Microbiome Presence (C_Actinobacteria)
20638,Free Cholesterol In Medium Vldl,Phenotype,Free Cholesterol In Medium Vldl
20641,Cerebrospinal Ab1-42 Levels In Normal Cognition,Phenotype,Cerebrospinal Ab1-42 Levels In Normal Cognition
20643,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492),Phenotype,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492)
20645,Platelet Side Scatter Distribution Width,Phenotype,Platelet Side Scatter Distribution Width
20650,Intraocular Pressure,Phenotype,Intraocular Pressure
20653,Sphingomyelin (D38:0) Levels,Phenotype,Sphingomyelin (D38:0) Levels
20658,F-Chocolate/Coffee Liking (Derived Food-Liking Factor),Phenotype,F-Chocolate/Coffee Liking (Derived Food-Liking Factor)
20666,Triglyceride Levels In Non-Type 2 Diabetes,Phenotype,Triglyceride Levels In Non-Type 2 Diabetes
20669,Nsfl1C/Rwdd1 Protein Level Ratio,Phenotype,Nsfl1C/Rwdd1 Protein Level Ratio
20680,Cholesterol Levels X Vegetarianism Interaction,Phenotype,Cholesterol Levels X Vegetarianism Interaction
20696,Cyclothymic Temperament,Phenotype,Cyclothymic Temperament
20706,Ccn2/Dkk1 Protein Level Ratio,Phenotype,Ccn2/Dkk1 Protein Level Ratio
20708,Chronic Kidney Disease,Phenotype,Chronic Kidney Disease
20710,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test),Phenotype,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test)
20712,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder,Phenotype,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder
20718,Daytime Sleep Phenotypes,Phenotype,Daytime Sleep Phenotypes
20722,Ankylosing Spondylitis,Phenotype,Ankylosing Spondylitis
20727,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction
20741,Spontaneous Preterm Birth Without Premature Rupture Of Membranes,Phenotype,Spontaneous Preterm Birth Without Premature Rupture Of Membranes
20744,Catechol Sulfate Levels In Elite Athletes,Phenotype,Catechol Sulfate Levels In Elite Athletes
20751,R-6-Hydroxywarfarin Levels,Phenotype,R-6-Hydroxywarfarin Levels
20759,Externalizing Behaviour (Multivariate Analysis),Phenotype,Externalizing Behaviour (Multivariate Analysis)
20762,Plasma Betaine Levels In Chronic Kidney Disease,Phenotype,Plasma Betaine Levels In Chronic Kidney Disease
20766,Takayasu Arteritis,Phenotype,Takayasu Arteritis
20770,Vaginal Microbiome Metacyc Pathway (Pwy-7234|Inosine-5'-Phosphate Biosynthesis Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7234|Inosine-5'-Phosphate Biosynthesis Iii)
20773,Monocyte Side Scatter,Phenotype,Monocyte Side Scatter
20782,Covid-19 Death (Death Vs Tested And Survived),Phenotype,Covid-19 Death (Death Vs Tested And Survived)
20784,Interferon Alpha/Beta Receptor 1 (Analyte X9183.7) Levels,Phenotype,Interferon Alpha/Beta Receptor 1 (Analyte X9183.7) Levels
20786,Serum 25-Hydroxyvitamin D Levels,Phenotype,Serum 25-Hydroxyvitamin D Levels
20794,Collagen Alpha-2(Vi) Chain Levels,Phenotype,Collagen Alpha-2(Vi) Chain Levels
20796,Hearing Aid Use,Phenotype,Hearing Aid Use
20801,Isthmus-Cingulate Cortex Volume,Phenotype,Isthmus-Cingulate Cortex Volume
20803,Maximum Habitual Alcohol Consumption,Phenotype,Maximum Habitual Alcohol Consumption
20805,Dll1/Nbl1 Protein Level Ratio,Phenotype,Dll1/Nbl1 Protein Level Ratio
20808,Trefoil Factor 1 Levels,Phenotype,Trefoil Factor 1 Levels
20813,Osteoarthritis (Self-Reported),Phenotype,Osteoarthritis (Self-Reported)
20815,Ccn3/Col6A3 Protein Level Ratio,Phenotype,Ccn3/Col6A3 Protein Level Ratio
20817,Metabolonic Lactone Sulfate Levels,Phenotype,Metabolonic Lactone Sulfate Levels
20820,Allergic Disease,Phenotype,Allergic Disease
20825,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df),Phenotype,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df)
20828,Inflammatory Skin Disease,Phenotype,Inflammatory Skin Disease
20831,Triamcinolone Acetonide-Induced Ocular Hypertension,Phenotype,Triamcinolone Acetonide-Induced Ocular Hypertension
20834,Never Eat Eggs Vs No Eggs Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Eggs Vs No Eggs Restrictions (Ukb Data Field 6144)
20836,Transforming Growth Factor Beta Receptor Type 3 Levels,Phenotype,Transforming Growth Factor Beta Receptor Type 3 Levels
20838,Anorectal Malformation,Phenotype,Anorectal Malformation
20842,Depressive Symptoms (Mtag),Phenotype,Depressive Symptoms (Mtag)
20845,Cirrhosis,Phenotype,Cirrhosis
20848,"5,6-Dihydrothymine Levels",Phenotype,"5,6-Dihydrothymine Levels"
20850,Nonalcoholic Fatty Liver Disease (Imputed),Phenotype,Nonalcoholic Fatty Liver Disease (Imputed)
20857,Forns Index In High Alcohol Intake,Phenotype,Forns Index In High Alcohol Intake
20859,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes
20861,Apom/Mcam Protein Level Ratio,Phenotype,Apom/Mcam Protein Level Ratio
20865,Esophageal Squamous Cell Carcinoma,Phenotype,Esophageal Squamous Cell Carcinoma
20867,Trihexosylcermide (D18:1/22:0) Levels,Phenotype,Trihexosylcermide (D18:1/22:0) Levels
20869,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes,Phenotype,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes
20872,Spherical Equivalent,Phenotype,Spherical Equivalent
20875,Igg Digalactosylation Phenotypes (Multivariate Analysis),Phenotype,Igg Digalactosylation Phenotypes (Multivariate Analysis)
20876,Minimum Measurement Of Hepatic Fat,Phenotype,Minimum Measurement Of Hepatic Fat
20878,Urate Levels In Lean Individuals,Phenotype,Urate Levels In Lean Individuals
20880,Baff-R On Switched Memory B Cell,Phenotype,Baff-R On Switched Memory B Cell
20883,Idp Dmri Tbss L3 Sagittal Stratum R,Phenotype,Idp Dmri Tbss L3 Sagittal Stratum R
20885,Resting State Functional Connectivity Between Dorsal Anterior Insula And Left Putamen,Phenotype,Resting State Functional Connectivity Between Dorsal Anterior Insula And Left Putamen
20888,Bipolar Disorder (Body Mass Index Interaction),Phenotype,Bipolar Disorder (Body Mass Index Interaction)
20890,Gamma-Glutamyltryptophan Levels,Phenotype,Gamma-Glutamyltryptophan Levels
20893,Nicotine Withdrawal,Phenotype,Nicotine Withdrawal
20897,Neuronal Pentraxin Receptor Levels,Phenotype,Neuronal Pentraxin Receptor Levels
20905,Triacylglycerol(56:6)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(56:6)_[M+Nh4]1+ Levels
20912,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995)
20917,N-Acetylputrescine Levels,Phenotype,N-Acetylputrescine Levels
20919,Arylsulfatase A Levels,Phenotype,Arylsulfatase A Levels
20921,Btn2A1/Pik3Ip1 Protein Level Ratio,Phenotype,Btn2A1/Pik3Ip1 Protein Level Ratio
20923,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis)
20925,Interleukin-17 Receptor A Levels,Phenotype,Interleukin-17 Receptor A Levels
20927,Spherical Equivalent Or Myopia (Age Of Diagnosis),Phenotype,Spherical Equivalent Or Myopia (Age Of Diagnosis)
20929,Triacylglycerol(56:5)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(56:5)_[M+Nh4]1+ Levels
20940,Bin2/Snap29 Protein Level Ratio,Phenotype,Bin2/Snap29 Protein Level Ratio
20943,Wg Lh Intensity-Contrast Superiortemporal,Phenotype,Wg Lh Intensity-Contrast Superiortemporal
20945,Lung Cancer,Phenotype,Lung Cancer
20948,Heschl'S Gyrus Morphology,Phenotype,Heschl'S Gyrus Morphology
20951,Total Trihexosylcermide Levels,Phenotype,Total Trihexosylcermide Levels
20958,Disruptive Behavior (Multivariate Analysis),Phenotype,Disruptive Behavior (Multivariate Analysis)
20960,Mortality In Covid-19,Phenotype,Mortality In Covid-19
20962,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis)
20964,Gamma-Tocopherol/Beta-Tocopherol Levels,Phenotype,Gamma-Tocopherol/Beta-Tocopherol Levels
20969,Contamination Dimension In Obsessive Compulsive Disorder,Phenotype,Contamination Dimension In Obsessive Compulsive Disorder
20975,F-Fish Liking (Derived Food-Liking Factor),Phenotype,F-Fish Liking (Derived Food-Liking Factor)
20977,2-O-Methylascorbic Acid Levels,Phenotype,2-O-Methylascorbic Acid Levels
20980,Impaired Insulin Sensitivity In Response To N-3 Pufa Supplementation,Phenotype,Impaired Insulin Sensitivity In Response To N-3 Pufa Supplementation
20988,Cerebrospinal Fluid 5-Methyluridine (Ribothymidine) Levels,Phenotype,Cerebrospinal Fluid 5-Methyluridine (Ribothymidine) Levels
20993,Idp Dmri Tbss Fa Genu Of Corpus Callosum,Phenotype,Idp Dmri Tbss Fa Genu Of Corpus Callosum
20997,Discordance In Emotional Problems In Monozygotic Twins,Phenotype,Discordance In Emotional Problems In Monozygotic Twins
21000,Testasv_32 (Ruminococcaceae) Abundance,Phenotype,Testasv_32 (Ruminococcaceae) Abundance
21006,Hepcidin Concentration,Phenotype,Hepcidin Concentration
21011,Osteoarthritis (With Total Hip Replacement),Phenotype,Osteoarthritis (With Total Hip Replacement)
21013,Pediatric Non-Alcoholic Fatty Liver Disease Activity Score,Phenotype,Pediatric Non-Alcoholic Fatty Liver Disease Activity Score
21014,Extremely High Intelligence,Phenotype,Extremely High Intelligence
21017,Parental Longevity (Father'S Age At Death),Phenotype,Parental Longevity (Father'S Age At Death)
21021,Ischemic Stroke,Phenotype,Ischemic Stroke
21023,Plasma N-Acetylproline Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylproline Levels In Chronic Kidney Disease
21025,Temporal Pole Thickness (Unadjusted For Global Measures),Phenotype,Temporal Pole Thickness (Unadjusted For Global Measures)
21031,Nevus Count Or Cutaneous Melanoma,Phenotype,Nevus Count Or Cutaneous Melanoma
21034,Smoking Cessation (Mtag),Phenotype,Smoking Cessation (Mtag)
21036,"Covid-19 (Severe Vs Tested, Not Severe)",Phenotype,"Covid-19 (Severe Vs Tested, Not Severe)"
21042,Otu97_73 (Prevotella) Abundance,Phenotype,Otu97_73 (Prevotella) Abundance
21044,Nonalcoholic Fatty Liver Disease,Phenotype,Nonalcoholic Fatty Liver Disease
21046,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction,Phenotype,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction
21048,Coronary Heart Disease,Phenotype,Coronary Heart Disease
21051,"Age-Related Diseases, Mortality And Associated Endophenotypes",Phenotype,"Age-Related Diseases, Mortality And Associated Endophenotypes"
21052,Myocardial Infarction (Early Onset),Phenotype,Myocardial Infarction (Early Onset)
21053,Coronary Artery Disease Or Ischemic Stroke,Phenotype,Coronary Artery Disease Or Ischemic Stroke
21054,Coronary Artery Disease Or Large Artery Stroke,Phenotype,Coronary Artery Disease Or Large Artery Stroke
21056,"Coronary Artery Disease (Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Bypass Grafting, Angina Or Chromic Ischemic Heart Disease)",Phenotype,"Coronary Artery Disease (Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Bypass Grafting, Angina Or Chromic Ischemic Heart Disease)"
21057,Medication Use (Vasodilators Used In Cardiac Diseases),Phenotype,Medication Use (Vasodilators Used In Cardiac Diseases)
21058,Medication Use (Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease),Phenotype,Medication Use (Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease)
21059,Intracranial Aneurysm,Phenotype,Intracranial Aneurysm
21060,Psycho-Cardiometabolic Multimorbidity (Multivariate Analysis),Phenotype,Psycho-Cardiometabolic Multimorbidity (Multivariate Analysis)
21061,Type 2 Diabetes Mellitus Or Coronary Artery Disease (Pleiotropy),Phenotype,Type 2 Diabetes Mellitus Or Coronary Artery Disease (Pleiotropy)
21062,Coronary Artery Disease In Individuals Without Type 2 Diabetes,Phenotype,Coronary Artery Disease In Individuals Without Type 2 Diabetes
21063,Medication Use (Beta Blocking Agents),Phenotype,Medication Use (Beta Blocking Agents)
21076,Circulating Leptin Levels Adjusted For Bmi,Phenotype,Circulating Leptin Levels Adjusted For Bmi
21082,Hdl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Hdl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test)
21083,Hdl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test),Phenotype,Hdl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test)
21086,Triglyceride Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Triglyceride Levels X Short Total Sleep Time Interaction (2Df Test)
21087,Triglyceride Levels X Long Total Sleep Time Interaction (2Df Test),Phenotype,Triglyceride Levels X Long Total Sleep Time Interaction (2Df Test)
21088,Circulating Leptin Levels Or Type 2 Diabetes,Phenotype,Circulating Leptin Levels Or Type 2 Diabetes
21095,Joint Destruction In Rheumatoid Arthritis (Rapid Vs Slow),Phenotype,Joint Destruction In Rheumatoid Arthritis (Rapid Vs Slow)
21097,Two-Hour Glucose,Phenotype,Two-Hour Glucose
21110,Mood Instability,Phenotype,Mood Instability
21113,Waist-To-Hip Ratio Adjusted For Bmi X Sex Interaction,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi X Sex Interaction
21114,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction)
21115,Waist-To-Hip Ratio Adjusted For Bmi In Non-Smokers,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi In Non-Smokers
21116,Body Mass Index X Sex X Age Interaction (4Df Test),Phenotype,Body Mass Index X Sex X Age Interaction (4Df Test)
21117,Feeling Nervous,Phenotype,Feeling Nervous
21136,Liver Enzyme Levels (Alanine Transaminase),Phenotype,Liver Enzyme Levels (Alanine Transaminase)
21150,Body Composition Traits,Phenotype,Body Composition Traits
21152,Fasting Blood Insulin Adjusted For Bmi,Phenotype,Fasting Blood Insulin Adjusted For Bmi
21159,Total_GRS,Phenotype,Total_GRS
21428,Lipodystrophy1,Phenotype,Lipodystrophy1
21429,ALPNeg,Phenotype,ALPNeg
21430,Lipodystrophy2,Phenotype,Lipodystrophy2
21431,HyperInsulin,Phenotype,HyperInsulin
21432,BetaCell_2,Phenotype,BetaCell_2
21433,BetaCell_1,Phenotype,BetaCell_1
21434,Apolipoprotein A (Apoa),Phenotype,Apolipoprotein A (Apoa)
21437,alcohol_consumption,Phenotype,alcohol_consumption
21439,Diastolic Blood Pressue,Phenotype,Diastolic Blood Pressue
21445,Systolic Blood Pressue,Phenotype,Systolic Blood Pressue
21448,Pulse Pressure Measurement,Phenotype,Pulse Pressure Measurement
21450,Type 2 Diabetes Mellitus_2024,Phenotype,Type 2 Diabetes Mellitus_2024
21453,Fasting Glucose Hm3,Phenotype,Fasting Glucose Hm3
21459,fibrinogen,Phenotype,fibrinogen
21474,CRP,Phenotype,CRP
21491,Interleukin 1 (Il-1),Phenotype,Interleukin 1 (Il-1)
21496,Fasting Insulin Hm3,Phenotype,Fasting Insulin Hm3
21537,Age,Phenotype,Age
21584,Interleukin 6 (Il-6),Phenotype,Interleukin 6 (Il-6)
21750,Insulin-Like Growth Factor 1 (Igf1),Phenotype,Insulin-Like Growth Factor 1 (Igf1)
21963,Apolipoprotein B (Apob),Phenotype,Apolipoprotein B (Apob)
